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U-Pin Polyamide Motif for Recognition of the DNA Minor Groove
Alexander Heckel and Peter B. Dervan*[a]
Abstract: DNA-binding hairpin pyrrole ± imidazole polyamides with -aminobuty-
ric acid as a turn-forming residue tolerate A ¥T or T ¥A base pairs under the turn.
U-pins–polyamides with a different turn–have been synthesized and their DNA
binding properties were studied. The two turn-forming residues are connected via the
ring nitrogens using variable length aliphatic linkers ((CH2)n, n 3 ± 6). Through
optimization of the linker length and the substituents at the 2-position of the pyrrole
residue on the U-turn, polyamides with G ¥C/C ¥G tolerant turns could be found,
which bind to DNA in a predictable manner.
Keywords: amino acids ¥ DNA
recognition ¥ pyrrole ± imidazole
polyamides ¥ U-pins
Introduction
Polyamides made from N-methylpyrrole (Py), N-methylimi-
dazole (Im) and N-methyl-3-hydroxypyrrole (Hp) amino
acids bind with high affinities and sequence specificities to
the minor groove of double stranded DNA. This opens the
door to an array of potential applications, for example
regulating gene expression and chromosomal staining.[1, 2]
The progression from the natural products netropsin and
distamycin to the current picture of DNA recognition with
polyamides has been summarized in a recent review article.[1a]
This journey has included systematic variations of atoms,
substituents, residues and entire motifs and the DNA-binding
characteristics of each variant have been measured by
quantitative footprinting titrations. Hairpin polyamides con-
sist of two strands of aromatic amino acids which are
positioned antiparallel side-by-side in the minor groove of
DNA. A pairing rule paradigm has been developed, wherein a
Py/Im pair targets a C ¥G base pair, while an Im/Py pair
targets a G ¥C base pair. Likewise, a Py/Hp combination
distinguishes A ¥T from T ¥A. A Py/Py pair is degenerate and
binds to both A ¥T and T ¥A but not to G ¥C or C ¥G.
Figure 1[3] shows a mnemonic to illustrate how polyamides
read the recognition pattern present in the minor groove. This
model presents our view of polyamides as modular DNA-
recognition tools, constructed using simple rules and a small
set of readily available monomer units (the residues). Poly-
amides target a considerable number of DNA sequences with
high affinity and selectivity; however, there are limitations.
Covalently linking the antiparallel polyamide strands with a
-aminobutyric acid residue (GABA) in the hairpin motif
affords higher affinity binders. This also ensures a heterodi-
meric[4] binding mode with the DNA and locks the register of
the two strands with respect to each other, increasing the
specificity.[5] However, the hairpin motif has a sequence
requirement under the GABA turn residue, tolerating only
A ¥T/T ¥A base pairs for steric reasons.[6] In a recent inves-
tigation the influence of different tail residues on G/C
tolerance was studied.[7] Here, the ability of a new turn motif
to provide a similar G/C tolerance at the other end of the
recognition site are explored.
The intolerance of a GABA turn toward G ¥C/C ¥G base
pairs is due to the conflict with the steric bulk presented by the
exocyclic amino group of a guanine residue. This NH2 group
points outwards from the bottom of the minor groove ™on∫
which the alkyl chain of the GABA turn lies. An alternative
way to connect two polyamide strands is the ™H-pin∫ motif[8, 9]
in which two N-methyl groups of central residues are
connected with an alkyl chain leading to polyamide molecules
that resemble the letter ™H∫ (Figure 2). While these mole-
cules have the potential to target G ¥C/C ¥G tracts they are
significantly different in their architecture from hairpin
polyamides because they have a branched structure. As a
result they are more difficult to synthesize especially on solid
phase.[9] Moving the bridge away from the internal residues,
toward the edge of the molecule creates a linear oligomer
resembling the letter ™U∫ (Figures 2 and 3).
We refer to this new class of polyamides as ™U-pins∫ and to
the turn as a ™U-turn∫. While this only seems to be a minor
change, there were some caveats: To tolerate adjacent G/C
base pairs, it was possible that the substituent R (Figure 3) on
the U-pin would have to be hydrogen, to avoid a steric clash.
Compared with the analogous hairpin polyamide 2, such a
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Figure 2. Three motifs for DNA-binding polyamides: Hairpin, U-pin and
H-pin. As opposed to the two former, the latter has a branched architecture
with a concomitant additional level of complication in the synthesis. In this
black-and-white pictogram representation imidazole residues are drawn as
black circles and pyrrole residues as open circles. A methyl amide tail is
drawn as a triangle, a -alanine residue as a diamond and an aminopropyl
group as a crescent with a ™∫ sign. For structural formulae of these
polyamides see Figure 3 and ref. [9]. The arrows indicate the NC
direction in the polyamide.
U-pin would have two fewer hydrogen bonds, and potentially
lower affinity. Furthermore, U-pins could theoretically bind to
DNA in modes other than the predicted ™normal∫ one
(Figure 4). U-pins could bind in reverse fashion, as is observed
for certain hairpin polyamides.[10]
Additionally, U-pins could extend and bind in a ™Z binding
mode∫ or, if the bridge were long enough, in a fully linear
binding mode. To address these questions, the U-pins 1a ± f
which have different linker lengths and substituents were
synthesized.
Results and Discussion
To prepare U-pins using estab-
lished solid-phase synthesis
methods,[11] it was necessary to
synthesize U-turn dimers
(Scheme 1). Starting from the
commercially available substi-
tuted pyrrole 3 compound 6was
obtained after nitration (4),
esterification (5), reduction
and Boc protection. Then imi-
dazole was alkylated with ace-
tyl-protected bromo alcohols of
different chain lengths to ob-
tain compounds 7a ± c. After
tricholoroacetylation the result-
ing trichloroketones 8a ± c were
converted to the O-deprotected
alcohols 9a ± c. To obtain the
dimer the alcohols were con-
verted to the respective iodides
using I2, PPh3 and imidazole.
After aqueous workup the
crude mixture of the iodide
and OPPh3 was directly used
for the alkylation of compound
6 to provide the compounds
10a ± c. This step was followed
by deprotection of the carbox-
ylic acid with TBAF and formation of methyl amides 11a ± c.
Finally, the building blocks 12a ± c were obtained after
saponification of the ethyl ester. Because compounds 12a ± c
readily decarboxylate upon acidification they were used as
their sodium salts.
The six-carbon bridged dimers 12d, 16 and 20 required a
slightly different route (Scheme 2). Since the requisite acetyl-
protected bromo alcohol is not commercially available, 1,6-
hexanediol as used as the starting material. After monoace-
tylation[12] (13) the protected diol was treated with I2, PPh3
and imidazole. The crude iodide obtained after aqueous
workup was used directly for the alkylation of imidazole
(7d). Trichloroacetylation (8d) and esterification afford-
ed compound 9d, which was converted to the iodide and
treated with the nitro-substituted pyrrole 5 to obtain com-
pound 14. Nitropyrrole 5 was found to give better alkylation
yields than Boc-aminopyrrole 6. Reduction and Boc protec-
tion of compound 14 provided compound 10d. Deprotection
and amide bond formation using MeNH2 or NH3 afforded
compounds 11d and 15, respectively. After saponification, the
carboxylic acid sodium salts 12d and 16 were obtained and
again used without acidification to avoid decarboxylation.
Preparing the minimally substituted component 18 using the
crude iodide 17 and 3-nitropyrrole[13] proved to be impractical,
due to separation difficulties–the use of purified iodide 17,[14]
however, proceeded smoothly. After reduction and Boc
protection (19), saponification afforded the sodium salt
20. The remaining building blocks for the solid-phase syn-
thesis were either commercially available or obtained accord-
Figure 1. Dip-and-bump-mnemonic for polyamides reading the recognition pattern of the DNA minor groove.
The pairing rules are represented as shape complementarities. Pyrrole residues are drawn in yellow, imidazole
residues in red and hydroxypyrrole residues in blue. The bottom of the minor groove (shown as a crescent)
presents its recognition pattern as a series of dips and bumps ± dips for hydrogen-bond acceptors and bumps for
hydrogen bond donors. A Py residue can be paired with itself (this combination tolerates but does not
discriminate between A ¥Tand T ¥A base pairs) or with an Im or an Hp residue. The former is drawn as a red ball
with a dip (a hydrogen bond acceptor position) matching the bump (the NH2 group) of a guanine base, the latter
as a blue ball with a bump symbolizing the steric bulk and hydrogen bond donor capability of the hydroxy group.
For polyamides with good binding affinities the following two rules must be obeyed: All bumps have to be
matched by a dip and vice versa. As only exception, a Py/Py pair with its neutral surface can match the dip of an
A ¥T base pair.[3]
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Figure 4. Representations of theoretically possible binding modes of
U-pins. In the ™normal∫ binding mode the NC direction of the
polyamide is parallel to the 5 3 direction of the DNA, whereas in the
reverse binding mode it is antiparallel. These two binding modes have been
observed for hairpin polyamides with the latter occurring in some
exceptional cases only.[10] Depending on the length of the bridge in the
U-turn, binding in a previously unknown ™Z binding mode∫ or–in case of
longer bridges–in a linear (or 1:1) binding mode could also be
theoretically possible. Since the upper and lower strands of the DNA are
arbitrarily defined, the polyamide could of course also fit into the minor
groove after a 180 rotation around an axis perpendicular to the helix
axis–given an appropriate recognition pattern in the minor groove.
ing to literature proce-
dures.[2, 15, 16] Following estab-
lished solid phase synthesis pro-
tocols[7, 11] and using oxime res-
in, the U-pins 1a ± f and the
hairpin 2 were synthesized and
purified by RP-HPLC
(Scheme 3).
At first the question of the
optimal linker length was ad-
dressed. Therefore, DNase I
footprinting titration experi-
ments were performed with
the U-pins 1a ±d and the hair-
pin polyamide 2 as reference
compound on a restriction frag-
ment of the plasmid pDEH9
(Figure 5). This 250 base-pair
sequence has several potential
binding sites of interest. Ideally,
the U-pins 1a ± f should read a
sequence 5-GGWC-3 (W
A,T). The site labeled ™A∫ is
the only match site on this
restriction fragment; sites ™B∫
and ™C∫ are both designed
single base pair mismatch sites.
Site ™D∫ contains overlapping
regions to which the U-pins
could bind in all of the unwant-
ed binding modes (see Fig-
ure 4). The lower left corner of
Figure 5 shows the result of a
footprinting titration with the
reference hairpin 2. The affinities to the respective binding
sites are summarized in Table 1. Reference hairpin 2 binds
with high affinity and specificity to the match site
(site ™A∫).
Surprisingly, the U-pins showed a very similar behavior. In
all cases the footprint at the match binding site is the
dominant feature. U-pins 1a, b and d bind the DNA with
affinities nearly equal to that of reference compound 2–a
surprising result since these U-pins have one hydrogen bond
less than the reference compound. Only U-pin 1c with a five-
carbon linker has a significantly lower affinity in this DNA
context. A recent study on H-pins[9] showed a similar behavior
for the linker lengths: polyamides with a 4- or 6-carbon bridge
displayed the highest affinities, while polyamides with a five-
carbon bridge displayed lower affinities.
Significantly, the U-pins bind DNA in the ™normal∫ mode
essentially exclusively. For example, no footprint is observed
at site D, where the U-pins could theoretically bind in several
possible undesired binding modes. Furthermore, the U-pins
display specificities for the match over the single base pair
mismatch site that are comparable to the ones of hairpin
polyamide 2. Non-specific binding was only observed with
U-pin 1d at 5 n or higher concentrations. Nonetheless, U-pin
1d displays significant DNA binding at concentrations below
5 n and it had the best overall affinity in the series.
Figure 3. A comparison between U-pins and hairpins. Right: The U-pins 1a ± f and the reference hairpin
polyamide 2 synthesized for this study. Left: Hydrogen bonding pattern of hairpins and–extrapolating–the
putative hydrogen bonding pattern of U-pins. In this ™exploded view∫ the minor groove of DNA is drawn as
ladder. The steps of the ladder are the planes of the base pairs which present their respective recognition
elements: electron pairs (two dots in a circle) and H-bond donors (H in a circle).
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The tolerance for G/C adjacent to the U-turn element was
examined using plasmid pAH2 which incorporates designed
sites 5-TGGTCX-3 that differ only in the base pair adjacent
to the core binding site (Figure 6). The XT site appears
twice because it is also part of the plasmid pUC19,[17] from
which pAH2 was cloned.
Figure 7 shows the results of the footprinting experiments
with reference hairpin polyamide 2 and U-pins 1d ± f. The
binding affinities to the respective sites are summarized in
Table 2 and represented graphically in Figure 8.
As expected, the GABA residue of the hairpin polyamide 2
tolerates an A ¥Tor T ¥A base pair at the turn position, but the
binding affinity drops by one order of magnitude for XC
and no binding was observed for XG in the concentration
ranges used. This confirms the trend which had been
previously found for hairpin polyamides.[6] U-pins 1b and d
(with methyl amide substituents) encounter a lower energetic
penalty for binding the sites with XC or G, but these
compounds also bind with slightly lower affinities than hairpin
polyamide 2. As pointed out earlier, a U-pin, such as 1b or d,
has one hydrogen bond less than a comparable hairpin
polyamide such as 2. Interestingly, in this DNA context U-pin
1b showed approximately the same affinity as U-pin 1d, while
















































































Scheme 1. Synthesis of the U-turn building blocks 12a ± c. a) HNO3, Ac2O; b) TMSEOH, NaH; c) 1. H2, Pd/C, 2. Boc2O, NaHCO3; d) Br(CH2)nOAc, NaH;



















































































b) k) g) j)
b)  f) g) h)  i) j)
a) b)  c) d) e)
13
7d 8d 9d
14 10d 11d: R=NHMe  15: R=NH2
12d: R=NHMe
  16: R=NH2
17
18 19 20
Scheme 2. Synthesis of the U-turn building blocks 12d, 16 and 20. a) Ce(SO4)2/silica gel, EtOAc; b) I2, PPh3, Im; c) Im, NaH; d) Cl3CCOCl; e) NaOEt; f) 5,
K2CO3; g) H2, Pd/C, Boc2O; h) TBAF; i) 1. DCC, HOBt, 2. MeNH2 or NH3, DIEA; j) NaOH; k) 3-nitropyrrole,[13] K2CO3.
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derived from the plasmid pDEH9 (cf. Figure 5 and Table 1).
Reducing the size of the ring substituent further increases the
tolerance for C or G adjacent to the turn residue: U-pin 1e
with the primary amide substituent, tolerates the three base
pairs A ¥T, T ¥A and C ¥Gwith equal affinities. However, a G ¥
C base pair (where the exocyclic NH2 group of the G base is
closer to the substituent on the U-turn as in a C ¥G pair) still
causes a drop in affinity. Only U-pin 1 f with the unsubstituted
turn tolerates all base pairs equally. Its affinity is again lower
which was to be expected since this U-pin has one hydrogen
bond less than U-pins 1b, d and e and two hydrogen bonds less
than the hairpin polyamide 2. As a reference, six-ring hairpin
polyamides which have the same number of hydrogen bonds
generally bind with an equilibrium association constant of Ka
1081.[18]
Summary and Outlook
In summary, we have presented a newmotif for minor groove-
binding pyrrole ± imidazole polyamides. The U-pins were
































































































































a) b) c) b) c)
b) d) b) e) f) g) b) c)
b) h) b) e) f) i)
b) h) b) e) f) i)
j)
j)
Scheme 3. Solid-phase synthesis of the U-pin polyamides 1a ± f and hairpin polyamide 2 on oxime resin. In the pictogram representation the linker of the
oxime resin is drawn as a gray bar and the pyrrole and imidazole residues as circles according to the rules explained in Figure 2. a) 3 equiv 21, 6 equiv DIEA,
DMF, 14 h, RT, wash with DMF, CH2Cl2; b) 25% TFA in CH2Cl2, 2 30 s, 2 10 min, wash with CH2Cl2, DMF, DMF/DIEA, DMF; c) 3 equiv 21, 6 equiv
DIEA, DMF, 2 h, RT, wash with DMF, CH2Cl2; d) 3 equiv 12a ± d, 16 or 20 (activated with 2.7 equiv HBTU, 6 equiv DIEA, DMF, 15 min, RT), 2 h, RT, wash
with DMF, CH2Cl2; e) 3 equiv 22 (activated with 2.7 equiv HBTU, 6 equiv DIEA, DMF, 15 min, RT), 2 h, RT, wash with DMF, CH2Cl2; f) 50% TFA in
CH2Cl2, 2 30 s, 2 10 min, wash with CH2Cl2, DMF, DMF/DIEA, DMF; g) 9 equiv 23 (activated with 7 equiv HBTU, 6 equiv DIEA, DMF, 15 min, RT),
14 h, 37 C, wash with DMF, CH2Cl2; h) 4 equiv 24 (activated with 3.8 equiv HOBt, 3.8 equiv DCC, DMF, 2.5 h, RT), 6 equiv DIEA, 2 h, RT, wash with DMF,
CH2Cl2; i) 7 equiv 25 (activated with 4 equiv HBTU, 6 equiv DIEA, DMF, 20 min, RT), 14 h, 37 C, wash with DMF, CH2Cl2, CH2Cl2/MeOH, CH2Cl2;
j) saturated solution of MeNH2 in MeOH, 1 h, 37 C, wash with MeOH, CH2Cl2, MeOH.
Table 1. Equilibrium association constants [1] obtained in DNase I footprint-
ing experiments with the EcoRI/PvuII restriction fragment of the plasmid
pDEH9 and the polyamides 1a ± d and 2 (see also Figure 5). All experiments
were performed at least three times. Given are the average values and the
standard deviations (in parentheses).
Polyamide 5-TGGTCA-3 5-TGGCCA-3 5-TGGGCA-3
(site ™A∫) (site ™B∫) (site ™C∫)
1a (n 3, RCONHMe) 7.7 109 (1.1)  1 108  2 108
1b (n 4, RCONHMe) 8.0 109 (1.2)  108  108
1c (n 5, RCONHMe) 2.6 109 (0.5)  108  108
1d (n 6, RCONHMe) 1.7 1010 (0.3) (5 108)[a] (5 108)[a]
2 (hairpin) 1.3 1010 (0.2)  4 108  7 108
[a] At this threshold polyamide 1d binds nonspecifically to the DNA fragment.
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Figure 5. Results of DNase I footprinting experiments with the EcoRI/PvuII restriction fragment of the plasmid pDEH9 and the polyamides 1b, d and 2. In
the lower right corner the sequence of the restriction fragment is shown (insert used for cloning in bold-face) and the four binding sites of interest are labeled
A, B, C and D (for a discussion see text). The only match site for such a U-pin is site A. The numbers indicate the position on the DNA fragment.
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Figure 6. Sequence of the EcoRI/PvuII restriction fragment of the plasmid
pAH2. The binding sites of interest are marked with boxes. The insert used
in the cloning process is shown in bold face.
theoretically bind to DNA in different binding modes (Fig-
ure 4), only binding in the so-called ™normal∫ mode was
observed and the U-pins showed good selectivity for binding
to match over mismatch sites. U-pins tolerate several different
linker lengths with the exception of five linking carbon atoms.
Probing the influence of the substitution of the turn on G/C
tolerance, it was found that U-pin 1e is best for tolerating a
C ¥G base pair. Finally, in order to target a DNA sequence in a
larger context which has a G ¥C base pair in the turn region it
was necessary to remove all substituents on the U-turn, as
evident from the binding behavior of U-pin 1 f. The U-pin
motif extends the repertoire of DNA sites that can be targeted
by polyamides.
Experimental Section
Compounds 21,[11a] 22,[11a] 24[2, 9] and 25[16] were obtained according to
literature procedures. All other chemicals used were purchased from
Aldrich. All reactions were performed under an Ar atmosphere and using
dry solvents. NMR spectra were recorded on a 300 MHz Varian Mercury
spectrometer. The spectra were referenced as indicated, using reported
chemical shifts for the respective signals.[19] Peaks were assigned by 2D
NMR spectroscopy and by comparison. UV/Vis spectra were recorded on a
Hewlett-Packard 8452A diode array spectrometer. High resolution mass
spectrometry was performed at the Mass Spectrometry Facility of the
University of California, Los Angeles (UCLA). All other mass spectra
were recorded at the mass spectrometry facility of the Division of
Chemistry and Chemical Engineering at Caltech. Analytical HPLC:
Beckman System Gold, 125 Solvent Module, 168 Detector, 508 Autosam-
pler, software: Gold Nouveau V1.7, unless otherwise noted the following
conditions were used: column: Varian Microsorb MV 300-8 C18, flow:
1 mLmin1, solvents: A 0.1% TFA in H2O, BMeCN, gradient: 0
60% B linear in 30 min. Preparative HPLC: Beckman System Gold, 127P
Solvent Module, 166P Detector, columns: 1) Waters PrepLC 25 mm
module, 2) Hamilton PRP-1, unless otherwise noted the following con-
ditions were used: solvents: A 0.1% TFA in H2O, BMeCN, gradient:
0% B (0 min), 0% B (5 min), 20% B (30 min), 25% B (50 min), 35% B
(60 min), 45% B (70 min), linear. Unless otherwise noted, enzymes were
purchased from Roche. The oligonucleotides (inserts) used for the
preparation of the plasmids were obtained from the Oligonucleotide
Synthesis Facility of the Beckman Institute at the California Institute of
Technology. Sequencing of oligonucleotides was performed by the Se-
quence Analysis Facility, Division of Biology, California Institute of
Technology. Radioactively labeled nucleotides were purchased from
Perkin ±Elmer. The footprinting experiments were performed according
to published procedures[20] using the general rule of  8690 Lmol1 cm1
per ring in a polyamide for the quantification which turned out to also hold
for U-pins. To quantify the gels they were exposed over night on Kodak
storage phosphor screens (SO230, purchased from Molecular Dynamics).
To obtain the images, the storage phosphor screen was scanned on a
Typhoon 8600 phosphorimager from Molecular Dynamics. For the analysis
the software ImageQuant (version 5.1) was used and the equilibrium
affinity constants were determined according to previously published
methods.[20] Abbreviations used: TMSE: trimethylsilylethyl, DCC: dicy-
clohexylcarbodiimide, HOBt: hydroxybenzotriazole, HBTU: 2-(1H-ben-
zotriazole-1-yl)-1,1,3,3-tetramethyluronium hexa-fluorophosphate, DIEA:
H¸nig×s base, Phth: ortho-phthalimide.
U-pins 1a ± f : The U-pins for this study were all prepared according to
reported solid phase synthesis protocols[7] on oxime resin (Novabiochem,
catalogue number 01-64-002, 0.48 mmolg1) and using the conditions
detailed in Scheme 3. The U-pins were stored at 80 C and the purity of
this stock was rechecked at the end of this study.
U-pin 1a : 1H NMR (300 MHz, DMSO, 25 C, DMSO):  1.97 (m, 2H;
N(Py)CH2CH2CH2NH3), 2.18 (m, 2H; N(Py)CH2CH2CH2N(Im)), 2.66
(m, 8H; 2CONHCH3N(Py)CH2CH2CH2NH3), 3.75 (s, 3H; NMe), 3.76
(s, 3H; NMe), 3.82 (s, 3H; NMe), 3.83 (s, 3H; NMe), 3.99 (s, 3H; NMe),
4.30 ± 4.32 (m, 4H; N(Py)CH2CH2CH2NH3N(Py)CH2CH2CH2N(Im)),
4.46 (m, 2H; N(Py)CH2CH2CH2N(Im)), 6.79 ± 7.57 (m; arom. H), 7.64 (m,
3H; NH3), 7.93 ± 7.97 (m, 2H; 2CONHMe), 9.72 (s, 1H; amide NH), 9.89
(s, 1H; amide NH), 9.96 (s, 1H; amide NH), 10.06 (s, 1H; amide NH), 10.42
(s, 1H; amide NH), 10.50 (s, 1H; amide NH); analytical HPLC: tR
18.87 min; preparative HPLC: tR 46 min; UV/Vis (H2O): max 244,
317 nm; MS (MALDI): m/z : calcd for C50H58N20O8: 1066.48; found:
1105.40 [MK] , 1089.43 [MNa] , 1067.44 [MH] .
U-pin 1b : 1H NMR (300 MHz, DMSO, 25 C, DMSO):  1.69 (m, 4H;
N(Py)CH2CH2CH2CH2N(Im)), 1.98 (m, 2H; N(Py)CH2CH2CH2NH3),
2.67 (m, 8H; 2CONHCH3N(Py)CH2CH2CH2NH3), 3.78 (s, 3H; NMe),
3.82 (s, 3H; NMe), 3.83 (s, 3H; NMe), 4.00 (s, 6H; 2NMe), 4.29 (m, 2H;
N(Py)CH2CH2CH2CH2N(Im)), 4.35 (m, 2H; N(Py)CH2CH2CH2NH3),
Table 2. Equilibrium association constants [1] obtained in DNase I footprinting experiments with the EcoRI/PvuII restriction fragment of the plasmid
pAH2 and the polyamides 1b, d ± f and 2 (see also Figures 6 ± 8). All experiments were performed at least three times. Given are the average values and the
standard deviations (in brackets).
Polyamide 5-TGGTCA-3 5-TGGTCT-3 5-TGGTCC-3 5-TGGTCG-3
1b (n 4, RCONHMe) 6.3 109 (1.5) 8.9 109 (1.4) 2.4 109 (0.3) 1.8 108 (0.1)
1d (n 6, RCONHMe) 4.1 109 (0.9) 6.5 109 (1.4) 2.0 109 (1.0) 2.0 108 (0.5)
1e (n 6, RCONH2) 2.6 109 (0.9) 2.6 109 (1.0) 2.8 109 (1.2) 4.1 108 (1.5)
1f (n 6, RH) 2.3 108 (0.4) 4.4 108 (0.5) 2.9 108 (0.8) 1.8 108 (0.2)
2 (hairpin) 1.3 1010 (0.1) 1.4 1010 (0.1) 1.5 109 (0.2)  5 107
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4.44 (m, 2H; N(Py)CH2CH2CH2CH2N(Im)), 6.79 ± 7.57 (m; arom. H), 7.65
(m, 3H; NH3), 7.90 ± 7.95 (m, 2H; 2CONHMe), 9.70 (s, 1H; amide NH),
9.88 (s, 1H; amide NH), 9.94 (s, 1H; amide NH), 10.02 (s, 1H; amide NH),
10.40 (s, 1H; amide NH), 10.44 (s, 1H; amide NH); analytical HPLC: tR
19.58 min; preparative HPLC: tR 50 min; UV/Vis (H2O): max () 250
(4.67 104), 312 nm (6.91 104 Lmol1 cm1); MS (MALDI): m/z : calcd
for C51H60N20O8: 1080.49; found: 1119.50 [MK] , 1103.47 [MNa] ,
1081.51 [MH] .
U-pin 1c : 1H NMR (300 MHz, DMSO, 25 C, DMSO):  1.21 (m, 2H;
N(Py)CH2CH2CH2CH2CH2N(Im)), 1.66 (m, 2H; N(Py)CH2CH2CH2-
CH2CH2N(Im)), 1.75 (m, 2H; N(Py)CH2CH2CH2CH2CH2N(Im)), 1.96
Figure 7. Results of DNase I footprinting experiments with the EcoRI/PvuII restriction fragment of the plasmid pAH2 (see Figure 6) and the polyamides
1d ± f and 2. The numbers indicate the base-pair position and correspond to those in Figure 6.
U-Pin Polyamide Motif 3353±3366
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(m, 2H; N(Py)CH2CH2CH2NH3), 2.67 (m, 8H; 2CONHCH3
N(Py)CH2CH2CH2NH3), 3.78 (s, 3H; NMe), 3.82 (s, 3H; NMe), 3.83 (s,
3H; NMe), 3.99 (s, 6H; 2NMe), 4.24 (m, 2H; N(Py)CH2CH2CH2CH2CH2-
N(Im)), 4.35 (m, 2H; N(Py)CH2CH2CH2NH3), 4.40 (m, 2H;
N(Py)CH2CH2CH2CH2CH2N(Im)), 6.78 ± 7.58 (m; arom. H), 7.66 (m, 3H;
NH3), 7.93 (m, 2H; 2CONHMe), 9.72 (s, 1H; amide NH), 9.89 (s, 1H;
amide NH), 9.95 (s, 1H; amide NH), 10.03 (s, 1H; amide NH), 10.42 (s, 1H;
amide NH), 10.46 (s, 1H; amide NH); analytical HPLC: tR 20.18 min;
preparative HPLC: tR 54 min; UV/Vis (H2O): max () 244, 311 nm; MS
(MALDI): m/z : calcd for C52H62N20O8: 1094.51; found: 1138.48 [MK] ,
1117.51 [MNa] , 1095.55 [MH] .
U-pin 1d : 1H NMR (300 MHz, DMSO, 25 C, DMSO):  1.23 (m, 4H;
N(Py)CH2CH2CH2CH2CH2CH2N(Im)), 1.61 (m, 2H; N(Py)CH2CH2-
CH2CH2CH2CH2N(Im)), 1.73 (m, 2H; N(Py)CH2CH2CH2CH2CH2CH2-
N(Im)), 1.97 (m, 2H; N(Py)CH2CH2CH2NH3), 2.67 (m, 8H; 2CON-
HCH3N(Py)CH2CH2CH2NH3), 3.78 (s, 3H; NMe), 3.82 (s, 3H; NMe),
3.83 (s, 3H; NMe), 3.99 (s, 6H; 2NMe), 4.22 (m, 2H;
N(Py)CH2CH2CH2CH2CH2CH2N(Im)), 4.35 (m, 2H; N(Py)CH2-
CH2CH2NH3), 4.38 (m, 2H; N(Py)CH2CH2CH2CH2CH2CH2N(Im)),
6.76 ± 7.58 (m; arom. H), 7.65 (m, 3H; NH3), 7.92 (m, 2H; 2CONHMe),
9.72 (s, 1H; amide NH), 9.90 (s, 1H; amide NH), 9.96 (s, 1H; amide NH),
10.03 (s, 1H; amide NH), 10.43 (s, 1H; amide NH), 10.47 (s, 1H; amide
NH); analytical HPLC: tR 22.28 min; preparative HPLC: tR 73 min,
gradient: 0% B (0 min), 0% B (5 min), 25% B (60 min), 35% B (90 min),
45% B (100 min), linear; UV/Vis (H2O): max () 252, 312 nm; MS
(MALDI): m/z : calcd for C53H64N20O8: 1108.53; found: 1147.45 [MK] ,
1131.49 [MNa] , 1109.53 [MH] .
U-pin 1e : 1H NMR (300 MHz, DMSO, 25 C, DMSO):  1.24 (m, 4H;
N(Py)CH2CH2CH2CH2CH2CH2N(Im)), 1.62 (m, 2H; N(Py)CH2CH2-
CH2CH2CH2CH2N(Im)), 1.73 (m, 2H; N(Py)CH2CH2CH2CH2CH2CH2-
N(Im)), 1.98 (m, 2H; N(Py)CH2CH2CH2NH3), 2.68 (m, 6H; CON-
HCH3N(Py)CH2CH2CH2NH3), 3.79 (s, 3H; NMe), 3.83 (s, 3H;
NMe), 3.84 (s, 3H; NMe), 4.00 (s, 6H; 2NMe), 4.24 (m, 2H;
N(Py)CH2CH2CH2CH2CH2CH2N(Im)), 4.36 (m, 2H; N(Py)CH2CH2-
CH2NH3), 4.42 (m, 2H; N(Py)CH2CH2CH2CH2CH2CH2N(Im)), 6.79 ±
7.58 (m; arom. H), 7.66 (m, 3H; NH3), 7.93 (m, H; CONHMe), 9.73 (s,
1H; amide NH), 9.90 (s, 1H; amide NH), 9.96 (s, 1H; amide NH), 10.01 (s,
1H; amide NH), 10.43 (s, 1H; amide NH), 10.47 (s, 1H; amide NH);
analytical HPLC: tR 21.15 min; preparative HPLC: tR 70 min, gradient:
0% B (0 min), 0% B (5 min), 25% B (60 min), 35% B (90 min), 45% B
(100 min), linear; UV/Vis (H2O): max () 252, 314 nm; MS (MALDI):
m/z : calcd for C52H62N20O8: 1094.51; found: 1117.25 [MNa] , 1095.24
[MH] .
U-pin 1 f : 1H NMR (300 MHz, DMSO, 25 C, DMSO):  1.24 (m, 4H;
N(Py)CH2CH2CH2CH2CH2CH2N(Im)), 1.64 (m, 2H; N(Py)CH2CH2-
CH2CH2CH2CH2N(Im)), 1.72 (m, 2H; N(Py)CH2CH2CH2CH2CH2CH2-
N(Im)), 1.97 (m, 2H; N(Py)CH2CH2CH2NH3), 2.67 (m, 6H; CON-
HCH3N(Py)CH2CH2CH2NH3), 3.79 (m, 5H; NMeN(Py)CH2-
CH2CH2CH2CH2CH2N(Im)), 3.82 (s, 3H; NMe), 3.83 (s, 3H; NMe), 3.99
(s, 6H; 2NMe), 4.34 (m, 2H; N(Py)CH2CH2CH2NH3), 4.42 (m, 2H;
N(Py)CH2CH2CH2CH2CH2CH2N(Im)), 6.06 (m, 1H; arom. H), 6.56 (m,
1H; arom. H), 6.79 ± 7.58 (m; arom. H), 7.65 (m, 3H; NH3), 7.92 (m, H;
CONHMe), 9.72 (s, 1H; amide NH), 9.88 (s, 1H; amide NH), 9.90 (s, 1H;
amide NH), 9.95 (s, 1H; amide NH), 10.40 (s, 1H; amide NH), 10.47 (s, 1H;
amide NH); analytical HPLC: tR 22.93 min; preparative HPLC: tR
76 min, gradient: 0% B (0 min), 0% B (5 min), 25% B (60 min), 35% B
(90 min), 45% B (100 min), linear; UV/Vis (H2O): max () 250, 314 nm;
MS (MALDI): m/z : calcd for C51H61N19O7: 1051.50; found: 1090.72
[MK] , 1074.72 [MNa] , 1052.80 [MH] .
Hairpin-polyamide 2 : This compound was prepared according to reported
solid phase synthesis strategies[7] on oxime resin (Novabiochem, catalogue
number 01-64-002, 0.48 mmolg1) and using the conditions detailed in
Scheme 3. 1H NMR (300 MHz, DMSO, 25 C, DMSO):  1.80 (m, 2H;
NCH2CH2CH2CO (GABA)), 2.00 (m, 2H; N(Py)CH2CH2CH2NH3), 2.36
(t, 3J(H,H) 6.6 Hz, 2H; NCH2CH2CH2CO (GABA)), 2.68 (d, 3J(H,H)
4.4 Hz, 3H; CONHCH3), 2.76 (m, 2H; N(Py)CH2CH2CH2NH3), 3.20 (m,
2H; NCH2CH2CH2CO (GABA)), 3.54 (s, 3H; NMe), 3.80 (s, 3H; NMe),
3.81 (s, 3H; NMe), 3.84 (s, 3H; NMe), 3.86 (s, 3H; NMe), 3.96 (s, 3H;
NMe), 4.01 (s, 3H; NMe), 4.38 (m, 2H; N(Py)CH2CH2CH2NH3), 6.81 ±
7.67 (m; arom. H), 7.94 (d, 3J(H,H) 4.4 Hz, 1H; CONHCH3), 8.06 (m,
1H; NHCH2CH2CH2CO (GABA)), 9.74 (s, 1H; amide NH), 9.92 (s, 1H;
amide NH), 9.96 (s, 1H; amide NH), 10.00 (s, 1H; amide NH), 10.05 (s, 1H;
amide NH), 10.29 (s, 1H; amide NH), 10.45 (s, 1H; amide NH); analytical
HPLC: tR 19.30 min (column: Varian Microsorb MV 100-5C18, 250
4.6 mm); preparative HPLC: tR 49.5 min; UV/Vis (H2O): max 236,
314 nm; MS (MALDI): m/z : calcd for C52H61N21O9: 1123.50; found:
1162.40 [MK] , 1146.39 [MNa] , 1124.41 [MH] .
2,2,2-Trichloro-1-(4-nitro-1H-pyrrol-2-yl)-ethanone (4): 2,2,2-Trichloro-1-
(1H-pyrrol-2-yl)-ethanone (209 g, 0.984 mol) was dissolved in Ac2O (1 L)
and the solution was cooled to 15 C. Then fuming HNO3 (113 mL) was
added very carefully, so that the temperature of the reaction mixture was
kept between 20 and 15 C. After the addition was finished the
temperature of the reaction mixture was slowly allowed to come to RTand
stirring was continued over night. Then the mixture was poured into ice
water. The precipitate was collected and dried. After coevaporating with
toluene several times the residue was again dried and recrystallized from
CHCl3/EtOH 95:5. Thus, compound 4 was isolated as beige solid (139 g,
0.540 mol, 55%). The spectroscopic data were in accord with literature
data.[2]
4-Nitro-1H-pyrrole-2-carboxylic-2-trimethylsilanyl ethyl ester (5): NaH
(0.8 g, 60%, 20.2 mmol, 0.2 equiv) was suspended in THF and 2-trime-
thylsilanyl-ethanol (16 mL, 13.2 g, 111 mmol, 1.1 equiv) was slowly added.
Then compound 4 (26 g, 101.0 mmol, 1 equiv) was dissolved in THF and
slowly added. After stirring at RT for 14 h the reaction mixture was
neutralized with conc. H2SO4 and the solvent was evaporated. Then CH2Cl2
(30 mL) and petroleum ether (80 mL) were added and the mixture was
kept in a freezer for several hours. After filtration, compound 5 was
isolated as a yellow powder (25.07 g, 97.8 mmol, 97%). The spectroscopic
data were in accord with literature data.[2]
4-tert-Butoxycarbonylamino-1H-pyrrole-2-carboxylic-2-trimethylsilanyl
ethyl ester (6): In a 1 L bomb compound 5 (75 g, 293 mmol, 1.0 equiv) was
suspended in EtOAc (500 mL) and EtOH (150 mL) and the suspension was
purged with Ar. Then Pd/C (30 g, 10%) was added and the bomb was
pressurized with H2 (25 bar). After 3 h the reaction mixture was filtered
through Celite and most of the solvent was evaporated. Then an aqueous
solution of NaHCO3 and Boc2O (96 g, 439.5 mmol, 1.5 equiv) were added
and the mixture was stirred at RT for 1 h. After separation of the phases the
aqueous layer was extracted twice with EtOAc. The combined organic
phases were dried with MgSO4 and the solvent was evaporated, affording a
yellowish powder which was dissolved in CH2Cl2 (100 mL), followed by
addition of petroleum ether (800 mL). After keeping this mixture in a
freezer for several hours, filtration afforded compound 6 as a colorless
powder (80.3 g, 249 mmol, 84%). The spectroscopic data was in accord
with literature data.[2]
Compounds 7a ± c : Detailed example for the preparation of compound 7b :
NaH (20 g, 60%, 0.499 mol, 1.00 equiv) was suspended in THF (90 mL).
Then a solution of imidazole (34 g, 0.499 mol, 1.00 equiv) in THF (200 mL)
was slowly added. The suspension was heated to reflux and more THF
Figure 8. Graphical representation of the binding affinities of the poly-
amides 1b, d ± f and 2 to the respective binding sites on the EcoRI/PvuII
restriction fragment of pAH2. For the numerical values see Table 2.
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(80 mL) was added. After dissolving acetic 4-bromo-butyl ester (99.3 g,
0.509 mol, 1.02 equiv) in THF (100 mL) this solution was added to the
reaction mixture. After heating to reflux for 20 h the reaction was allowed
to cool to room temperature, H2O (1 mL) was added and the solvent was
evaporated. The residue was partitioned between CH2Cl2 and H2O and the
aqueous phase was extracted twice with CH2Cl2. The combined organic
layers were extracted with brine, dried with MgSO4 and the solvent was
evaporated. Then the remaining orange oil was distilled under vacuum. To
remove traces of mineral oil the product was dissolved in dilute aqueous
HCl and the solution was extracted with petroleum ether. After neutral-
ization with K2CO3 the aqueous phase was extracted with CH2Cl2 (three
times). The combined organic layers were dried with MgSO4 and the
solvent was evaporated to obtain spectroscopically pure compound 7b as
colorless liquid (76.1 g, 0.418 mol, 84%). 1H NMR (300 MHz, CDCl3,
25 C, CHCl3):  1.58 ± 1.67 (m, 2H; CH2), 1.81 ± 1.91 (m, 2H; CH2), 2.04
(s, 3H; OAc), 3.99 (t, 3J(H,H) 7.1 Hz, 2H; CH2), 4.07 (t, 3J(H,H)
6.6 Hz, 2H; CH2), 6.92 (s, 1H; arom. H), 7.08 (s, 1H; arom. H), 7.58 (s,
1H; arom. H); 13C NMR (75 Hz, CDCl3, 25 C, CDCl3):  21.01, 25.75,
27.78, 46.62, 63.45, 118.62, 129.20, 136.84, 170.82; IR (CHCl3):   2966 (m),
1733 (s), 1508 (m), 1451 (w), 1390 (w), 1367 (m), 1224 (s), 1111 (w), 1078
(m), 1049 (m), 910 cm1 (w); HR-MS (ESI): calcd for C9H14N2O2: 182.1055;
found: 183.113 [MH] .
Compound 7a : Obtained similarly; the acetic 3-bromo-propyl ester used
was obtained by diluting 3-bromo-propanol (50 g, 0.36 mol, 1 equiv) with
CH2Cl2 (300 mL) and adding a preformed mixture of Ac2O (34 mL,
0.36 mol, 1 equiv) and Et3N (50 mL, 0.36 mol, 1 equiv). After stirring at RT
for 20 min an aqueous solution of NaHCO3 was added and the phases were
separated. The organic layer was extracted once more with aqueous
NaHCO3 and then with brine. After drying with MgSO4 the solvent was
evaporated and the residue distilled under reduced pressure, affording
acetic 3-bromo-propyl ester as colorless oil (53.0 g, 0.292 mol, 81%). Then,
using imidazole (32.0 g, 0.470 mol, 1 equiv), acetic 3-bromo-propyl ester
(86.7 g, 0.479 mol, 1.02 equiv) and NaH (18.8 g, 60%, 0.470 mol, 1 equiv),
compound 7awas isolated as slightly yellowish oil (49.1 g, 0.292 mol, 62%).
Rf (hexane/acetone 3:2) 0.38; 1H NMR (300 MHz, CDCl3, 25 C, CHCl3):
 2.03 (s, 3H; OAc), 2.07 (quint. , 3J(H,H) 6.0 Hz, 2H; CH2CH2CH2),
4.03 (m, 4H; CH2CH2CH2), 6.89 (d, 3J(H,H) 1.1 Hz, 1H; arom. H), 7.04
(d, 3J(H,H) 1.1 Hz, 1H; arom. H), 7.47 (s, 1H; arom. H); 13C NMR
(75 MHz, CDCl3, 25 C, CDCl3):  20.84, 30.16, 43.68, 60.82, 118.60,
129.45, 136.93, 170.52; IR (CHCl3):   2968 (m), 1738 (s), 1508 (m), 1454
(w), 1392 (w), 1369 (m), 1225 (s), 1110 (m), 1079 (m), 1050 (m), 910 (m),
818 cm1 (m); HR-MS (EI): calcd for C8H12N2O2: 168.0899; found:
168.0891 [M] .
Compound 7c : Obtained similarly, using imidazole (40.0 g, 0.587 mol,
1 equiv), acetic 5-bromo-pentyl ester (125.21 g, 0.599 mol, 1.02 equiv) and
NaH (23.5 g, 60%, 0.587 mol, 1 equiv), and isolated as colorless oil (77.5 g,
0.395 mol, 67%). 1H NMR (300 MHz, CDCl3, 25 C, CHCl3):  1.25 ± 1.38
(m, 2H; CH2), 1.58 ± 1.67 (m, 2H; CH2), 1.73 ± 1.84 (m, 2H; CH2), 2.01 (s,
3H; OAc), 3.93 (dt, 3J(H,H) 1.6, 7.1 Hz, 2H; CH2), 4.02 (dt, 3J(H,H)
1.6, 6.6 Hz, 2H; CH2), 6.88 (dd, 3J(H,H) 1.6, 2.7 Hz, 1H; arom. H), 7.03 (s,
1H; arom. H), 7.46 (s, 1H; arom. H); 13C NMR (75 MHz, CDCl3, 25 C,
CDCl3):  20.98, 23.03, 28.06, 30.68, 46.81, 63.87, 118.59, 129.20, 136.84,
170.85; IR (CHCl3):   2946 (m), 2867 (s), 1731 (s), 1509 (m), 1453 (w),
1391 (w), 1367 (m), 1245 (s), 1110 (m), 1078 (m), 1049 (m), 910 cm1 (w).
Compound 7d : Triphenylphosphine (33.9 g, 129 mmol, 1 equiv) and
imidazole (8.8 g, 129 mmol, 1 equiv) were dissolved in CH2Cl2. After
cooling with an ice bath, I2 (32.8 g, 129 mmol, 1 equiv) was slowly added.
After the addition was finished, the reaction mixture was stirred for
another 10 min at RT. Then acetic 6-hydroxy-hexyl ester (20.69 g,
129 mmol, 1 equiv)–prepared according to a literature procedure[12]–
was diluted with CH2Cl2 and slowly added to the previous reaction mixture,
which had again been cooled with an ice bath. After the addition was
finished the reaction mixture was stirred for another 10 min at RT and
extracted twice with an aqueous solution of Na2S2O3 and then with brine.
The organic layer was then dried with MgSO4 and the solvent was
evaporated, affording a colorless solid (67.9 g) which was dissolved in THF.
Then NaH (5.0 g, 60%, 125 mmol, 0.97 equiv) was washed with hexane and
suspended in THF. After imidazole (8.4 g, 125 mmol, 0.97 equiv) had been
dissolved in THF and added to the NaH suspension, the slurry was heated
to reflux and the THF solution of the iodide was added. Heating (reflux)
was continued for 2 h. Then the reaction mixture was allowed to cool to RT
and stirred over night. After quenching with H2O (1 mL), the solvent was
evaporated and H2O and CH2Cl2 were added. The aqueous layer was
extracted twice with CH2Cl2. The combined organic layers were extracted
with brine. Then most of the solvent was evaporated and aqueous HCl (1)
was added. After separation of the layers the organic phase was extracted
twice with dilute aqueous HCl. The combined aqueous layers were
neutralized with K2CO3 and the product was extracted three times with
CH2Cl2. After drying with MgSO4 the solvent was evaporated, affording
compound 7d as slightly brownish oil (22.8 g, 108 mmol, 84%). 1H NMR
(300 MHz, CDCl3, 25 C, CHCl3):  1.32 ± 1.38 (m, 4H; CH2), 1.62 (quint. ,
3J(H,H) 6.6 Hz, 2H; CH2), 1.79 (quint. , 3J(H,H) 7.1 Hz, 2H; CH2), 2.04
(s, 3H; OAc), 3.94 (t, 3J(H,H) 7.1 Hz, 2H; CH2), 4.04 (t, 3J(H,H)
6.6 Hz, 2H; CH2), 6.91 (s, 1H; arom. H), 7.06 (s, 1H; arom. H), 7.46 (s,
1H; arom. H); 13C NMR (75 MHz, CDCl3, 25 C, CDCl3):  21.01, 25.49,
26.23, 28.42, 30.98, 46.87, 64.16, 118.58, 129.28, 136.87, 170.93; IR (CHCl3):
  2942 (s), 2863 (m), 1732 (s), 1509 (s), 1465 (m), 1390 (m), 1368 (s), 1251
(s), 1110 (m), 1078 (s), 910 cm1 (m); HR-MS (ESI): calcd for C11H18N2O2:
210.1368; found: 211.1441 [MH] .
Compounds 8a ± d : Detailed example for the preparation of compound 8b :
Cl3CCOCl (20.6 mL, 33.6 g, 0.185 mol, 1.1 equiv) was diluted with CH2Cl2.
After cooling the solution to 5 C, compound 7b (30.6 g, 0.168 mol,
1 equiv), diluted with CH2Cl2 (50 mL), was slowly added so that the
temperature did not exceed 10 C. After stirring for 10 min at 5 C, Et3N
(23.4 mL, 0.168 mol, 1 equiv) was slowly added so that the temperature of
the reaction mixture did not exceed 15 C. After the addition was finished
the reaction mixture is diluted with CH2Cl2 and stirred at RT for 10 min.
Then the solvent was evaporated and EtOAc and an aqueous solution of
NaHCO3 were added. The organic layer was again extracted with aqueous
NaHCO3 and then with a 5% aqueous solution of citric acid. After drying
the organic layer with MgSO4, the solvent was evaporated, affording the
crude product as brownish oil (45.6 g, 0.139 mol, 83%). This product was
sufficiently pure for the following reactions. Since the product decomposes
very fast (even when kept at 20 C) it was always immediately used for
further reactions. To obtain an spectroscopically pure sample, the crude
product was dissolved in CH2Cl2 and filtered through silica gel, affording a
yellowish oil. Rf (hexane/acetone 3:2) 0.56; 1H NMR (300 MHz, CDCl3,
25 C, TMS):  1.72 (m, 2H; CH2), 1.90 (m, 2H; CH2), 2.07 (s, 3H; OAc),
4.12 (t, 3J(H,H) 6.0 Hz, 2H; CH2), 4.45 (t, 3J(H,H) 7.1 Hz, 2H; CH2),
7.23 (s, 1H; arom. H), 7.38 (s, 1H; arom. H); 13C NMR (75 MHz, CDCl3,
25 C, CDCl3):  21.00, 25.67, 27.59, 49.20, 63.40, 127.49, 130.62, 135.35,
170.84, 171.88; IR (CHCl3):   3002 (m), 2966 (m), 1732 (s), 1698 (m), 1662
(s), 1583 (w), 1502 (m), 1466 (m), 1438 (w), 1387 (s), 1366 (s), 1394 (m),
1246 (s), 1170 (w), 1120 (w), 1050 (w), 916 cm1 (w).
Compound 8a : Obtained similarly, using compound 7a (10 g, 59 mmol,
1 equiv), Cl3CCOCl (7.2 mL, 11.8 g, 65 mmol, 1.1 equiv) and Et3N (8.3 mL,
59 mmol, 1 equiv) and isolated as slightly yellowish liquid (11.8 g, 40 mmol,
67%). Rf (hexane/acetone 3:2) 0.52; 1H NMR (300 MHz, CDCl3, 25 C,
CHCl3):  2.06 (s, 3H; OAc), 2.17 (quint., 3J(H,H) 6.6 Hz, 2H; CH2),
4.11 (t, 3J(H,H) 6.0 Hz, 2H; CH2), 4.51 (t, 3J(H,H) 7.1 Hz, 2H; CH2),
7.22 (s, 1H; arom. H), 7.37 (s, 1H; arom. H); 13C NMR (75 MHz, CDCl3,
25 C, CDCl3):  20.93, 29.76, 46.68, 60.86, 94.76, 127.71, 130.67, 135.42,
170.62, 171.90; IR (CHCl3):   2998 (m), 1738 (s), 1699 (s), 1468 (m), 1387
(s), 1369 (m), 1242 (s), 1162 (w), 1078 (w), 1049 (m), 1018 (m), 918 cm1 (w).
Compound 8c : Obtained similarly, using compound 7c (77.5 g, 0.395 mol,
1 equiv), Cl3CCOCl (79.1 g, 0.435 mol, 1.1 equiv) and Et3N (55 mL,
0.395 mol, 1 equiv) and isolated as yellowish liquid (132.2 g, 0.387 mol,
98%). Rf (hexane/acetone 3:2) 0.57; 1H NMR (300 MHz, CDCl3, 25 C,
CHCl3):  1.45 (m, 2H; CH2), 1.71 (m, 2H; CH2), 1.88 (m, 2H; CH2), 2.05
(s, 3H; OAc), 4.07 (t, 3J(H,H) 6.6 Hz, 2H; CH2), 4.44 (t, 3J(H,H)
7.7 Hz, 2H; CH2), 7.27 (s, 1H; arom. H), 7.36 (s, 1H; arom. H); 13C NMR
(75 MHz, CDCl3, 25 C, CDCl3):  20.81, 22.80, 27.88, 30.33, 49.26, 63.68,
94.73, 127.44, 130.31, 135.04, 170.60, 171.49; IR (CHCl3):   2998 (m), 2958
(m), 2866 (w), 1732 (s), 1699 (s), 1662 (m), 1468 (m), 1437 (w), 1387 (s),
1367 (m), 1250 (s), 1167 (w), 1068 (w), 1047 (w), 1020 (m), 918 cm1 (w).
Compound 8d : Obtained similarly, using compound 7d (1.87 g, 8.89 mmol,
1 equiv), Cl3CCOCl (1.09 mL, 9.78 mmol, 1.1 equiv) and Et3N (1.24 mL,
8.89 mmol, 1 equiv), and isolated as yellowish oil (3.16g, 8.89 mmol, 99%).
Rf (hexane/acetone 3:2) 0.50; 1H NMR (300 MHz, CDCl3, 25 C, CHCl3):
 1.41 (m, 4H; 2CH2), 1.65 (m, 2H; CH2), 1.85 (m, 2H; CH2), 2.05 (s, 3H;
OAc), 4.06 (t, 3J(H,H) 6.6 Hz, 2H; CH2), 4.41 (t, 3J(H,H) 7.7 Hz, 2H;
CH2), 7.22 (s, 1H; arom. H), 7.37 (s, 1H; arom. H); 13C NMR (75 MHz,
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CDCl3, 25 C, CDCl3):  21.02, 25.49, 26.15, 28.43, 30.81, 49.57, 64.14,
94.82, 127.46, 130.47, 135.28, 170.92, 171.76; IR (CHCl3):   2996 (m), 2942
(s), 2863 (m), 1732 (s), 1698 (s), 1469 (s), 1438 (m), 1387 (s), 1368 (s), 1308
(m), 1243 (s), 1020 (s), 975 cm1 (s); MS (ESI): m/z (%): 355.2 (85)
[MH] , 313.2 (100), 295.2 (25), 213.1 (85).
Compounds 9a ± d : Detailed example for the preparation of compound 9b :
A solution of NaOEt was prepared by adding Na (3.18 g, 0.138 mol,
1 equiv) to EtOH (200 mL). After all Na had reacted, a solution of freshly
prepared compound 8b (45.3 g, 0.138 mol, 1 equiv) in EtOHwas added and
the reaction mixture was stirred over night at RT. Then the reaction
mixture was carefully neutralized with conc. H2SO4 and the solvent was
evaporated. After adding EtOAc and a saturated solution of NaHCO3 the
layers were separated and the aqueous layer was extracted twice with
EtOAc. The organic layers were combined, dried with MgSO4 and the
solvent was evaporated, affording compound 9b (24.8 g, 0.117 mol, 85%)
as an orange oil which could be used without any further purification. To
obtain an spectroscopically pure sample, the crude product was filtered
through silica gel using hexane/acetone 1:4 as solvent, affording a yellowish
oil. Rf (hexane/acetone 1:3) 0.47; 1H NMR (300 MHz, CDCl3, 25 C,
TMS):  1.42 (t, 3J(H,H) 7.1 Hz, 3H; OCH2CH3), 1.60 (quint.,
3J(H,H) 6.6 Hz, 2H; CH2), 1.91 (quint. , 3J(H,H) 7.1 Hz, 2H; CH2),
3.20 (br s, 1H; OH), 3.66 (t, 3J(H,H) 6.0 Hz; 2H, CH2OH), 4.36 ± 4.46 (m,
4H; OCH2CH3NCH2), 7.11 (s, 1H; arom. H), 7.12 (s, 1H; arom. H);
13C NMR (75 MHz, CDCl3, 25 C, CDCl3):  14.15, 27.68, 29.21, 48.11,
61.23, 61.41, 125.02, 129.00, 135.64, 158.67; IR (CHCl3):   2984 (m), 1710
(s), 1470 (m), 1422 (m), 1386 (m), 1258 (s), 1156 (w), 1118 (s); HR-MS
(MALDI): calcd for C10H16N2O3: 212.1161; found: 235.1051 [MNa] ,
213.1232 [MH] .
Compound 9a : Obtained similarly, using Na (400 mg, 17.5 mmol, 1 equiv)
and compound 8a (5.2 g, 17.5 mmol, 1 equiv) and isolated as yellow oil
(2.5 g, 13 mmol, 72%).Rf (hexane/acetone 1:3) 0.43; 1H NMR (300 MHz,
CDCl3, 25 C, CHCl3):  1.40 (t, 3J(H,H) 7.1 Hz, 3H; OCH2CH3), 2.03
(quint. , 3J(H,H) 6.0 Hz, 2H; CH2CH2CH2), 3.61 (t, 3J(H,H) 6.0 Hz;
2H, CH2OH), 4.36 (quart.brs, 3J(H,H) 7.1 Hz, 3H; OCH2CH3OH),
4.54 (t, 3J(H,H) 7.1 Hz, 2H; NCH2), 7.11 (s, 1H; arom. H), 7.18 (s, 1H;
arom. H); 13C NMR (75 MHz, CDCl3, 25 C, CDCl3):  13.96, 33.39,
44.91, 57.76, 61.16, 125.47, 128.69, 135.53, 158.51; IR (CDCl3):   3626 (w),
3524 (w), 2964 (w), 1707 (s), 1473 (m), 1422 (s), 1386 (m), 1308 (m), 1257
(s), 1182 (w), 1157 (w), 1116 (s); HR-MS (MALDI): calcd for C9H14N2O3:
198.1004; found: 221.0895 [MNa] , 199.1076 [MH] .
Compound 9c : Obtained similarly, using Na (9.3 g, 0.404 mol, 1.05 equiv)
and compound 8c (132.2 g, 0.387 mmol, 1 equiv) and isolated as yellowish
oil (79.1 g, 0.35 mol, 90%). Rf (hexane/acetone 1:3) 0.50; 1H NMR
(300 MHz, CDCl3, 25 C, TMS):  1.43 (m, 5H; OCH2CH3 , CH2), 1.59
(quint. , 3J(H,H) 6.6 Hz, 2H; CH2), 1.82 (quint. , 3J(H,H) 7.7 Hz, 2H;
CH2), 3.11 (br s, 1H; OH), 3.62 (t, 3J(H,H) 6.6 Hz; 2H, CH2OH), 4.36 ±
4.43 (m, 4H; OCH2CH3NCH2), 7.10 (s, 1H; arom. H), 7.13 (s, 1H; arom.
H); 13C NMR (75 MHz, CDCl3, 25 C, CDCl3):  14.10, 22.69, 30.84,
31.90, 48.27, 61.13, 61.79, 124.95, 128.94, 135.61, 158.59; IR (CHCl3):  
2986 (m), 2941 (m), 2867 (w), 1711 (s), 1473 (m), 1422 (s), 1386 (m), 1311
(w), 1258 (s), 1156 (m), 1117 (m), 1068 (m); HR-MS (MALDI): calcd for
C11H18N2O3: 226.1317; found: 249.1208 [MNa] , 227.1386 [MH] .
Compound 9d : Obtained similarly, using Na (202 mg, 8.8 mmol, 1.05 equiv)
and compound 8d (2.98 g, 8.38 mmol, 1 equiv) and isolated as yellowish oil
(1.75 g, 7.28 mmol, 87%). Rf (hexane/acetone 1:1) 0.27; 1H NMR
(300 MHz, CDCl3, 25 C, TMS):  1.25 ± 1.45 (m, 7H; OCH2CH32CH2),
1.52 ± 1.60 (m, 2H; CH2), 1.71 ± 1.87 (m, 3H; CH2OH), 3.63 (t, 3J(H,H)
6.0 Hz, 2H; CH2OH), 4.37 ± 4.47 (m, 4H; OCH2CH3NCH2), 7.15 (s, 1H;
arom. H), 7.29 (s, 1H; arom. H); 13C NMR (75 MHz, CDCl3, 25 C, CDCl3):
 14.35, 25.31, 26.32, 31.23, 32.52, 48.42, 61.38, 62.58, 125.07, 129.29,
157.15; IR (CHCl3):   3628 (m), 3392 (m), 2986 (s), 2940 (s), 2863 (s), 1711
(s), 1510 (w), 1473 (s), 1422 (s), 1386 (s), 1360 (m), 1311 (m), 1257 (s), 1156
(s), 1117 (s), 1070 (s), 1052 (m), 1019 (m), 925 cm1 (m); HR-MS (MALDI):
calcd for C12H20N2O3: 240.1474; found: 241.1549 [MH] .
Compounds 10a ± c : Detailed procedure for the preparation of compound
10b : PPh3 (5.53 g, 21.1 mmol, 1 equiv) and imidazole (1.44 g, 21.1 mmol,
1 equiv) were dissolved in CH2Cl2 and I2 (5.36 g, 21.1 mmol, 1 equiv) was
added. After 10 min stirring at RT compound 9b (4.5 g, 21.1 mmol, 1 equiv)
was diluted with CH2Cl2 and added. After 10 min stirring at RT the reaction
mixture was shaken with an aqueous solution of Na2S2O3 and the layers
were separated. The organic phase was extracted with brine, dried with
MgSO4 and the solvent was evaporated. Then the orange residue was
dissolved in MeCN, compound 6 (11.7 g, 36 mmol, 1.7 equiv) and K2CO3
(5.0 g, 36 mmol, 1.7 equiv) were added and the reaction mixture was heated
to 80 C for 22 h. After filtration the solvent was evaporated and CH2Cl2
and an aqueous solution of NaHCO3 were added. The aqueous layer was
extracted twice with CH2Cl2. Then the combined organic layers were
extracted with brine and dried with MgSO4. Evaporation of the solvent
afforded the crude product as a brown foam (22.7 g). Purification by flash
column chromatography (hexane/acetone 2:11% Et3N) afforded com-
pound 10b as slightly red foam (4.9 g, 9.4 mmol, 45%). Rf (hexane/acetone
1:1) 0.59; 1H NMR (300 MHz, DMSO, 25 C, TMS):  0.06 (s, 9H;
SiMe3), 1.05 (t, 3J(H,H) 8.2 Hz, 2H; CH2SiMe3), 1.42 (t, 3J(H,H) 7.1 Hz,
3H; OCH2CH3), 1.48 (s, 9; tBu), 1.78 (m, 4H; 2CH2), 4.25 ± 4.43 (m, 8H;
2COOCH22NCH2), 6.26 (br s, 1H; NH), 6.60 (d, 3J(H,H) 2.2 Hz, 1H;
arom. H), 7.06 (s, 1H; arom. H), 7.26 (s, 2H; arom. H); 13C NMR (75 MHz,
DMSO, 25 C, DMSO): 1.33 (SiMe3), 14.11 (OCH2CH3), 16.94
(CH2SiMe3), 27.88 (NCH2CH2CH2CH2N), 28.18 (C(CH3)3), 47.24 (NCH2),
47.45 (NCH2), 60.58 (COOCH2), 61.31 (COOCH2), 78.43 (C(CH3)3), 107.56,
118.11, 123.06 (2C), 126.24, 128.64, 135.21, 152.50, 158.40, 159.99; IR
(CDCl3):   3450 (w), 2983 (m), 1712 (s), 1587 (w), 1539 (w), 1472 (m),
1422 (m), 1401 (m), 1369 (m), 1253 (s), 1160 (s), 1118 cm1 (m); HR-MS
(MALDI): calcd for C25H40N4O6Si: 520.2717; found: 543.2611 [MNa] .
Compound 10a : Obtained similarly, using PPh3 (10.5 g, 40 mmol, 1 equiv),
imidazole (2.7 g, 40 mmol, 1 equiv), I2 (10.2 g, 40 mmol, 1 equiv), com-
pound 9a (7.9 g, 40 mmol, 1 equiv), compound 6 (23.5 g, 72 mmol,
1.8 equiv) and K2CO3 (10.0 g, 72 mmol, 1.8 equiv) and isolated as lightly
red foam (5.1 g, 10 mmol, 25%). Rf (hexane/acetone 1:1) 0.40; 1H NMR
(300 MHz, DMSO, 25 C, DMSO):  0.01 (s, 9H; SiMe3), 0.97 (t,
3J(H,H) 8.2 Hz, 2H; CH2SiMe3), 1.25 (t, 3J(H,H) 7.1 Hz, 3H;
OCH2CH3), 1.41 (s, 9; tBu), 2.00 ± 2.10 (m, 2H; CH2), 4.16 ± 4.34 (m, 8H;
2COOCH22NCH2), 6.62 (s, 1H; arom. H), 7.06 (s, 1H; arom. H), 7.12 (s,
1H; arom. H), 7.49 (s, 1H; arom. H), 9.14 (s, 1H; NH); 13C NMR (75 MHz,
DMSO, 25 C, DMSO): 0.57 (SiMe3), 14.88 (OCH2CH3), 17.71
(CH2SiMe3), 28.95 (C(CH3)3), 33.35 (NCH2CH2CH2CH2N), 46.19
(NCH2), 46.38 (NCH2), 61.32 (COOCH2), 62.13 (COOCH2), 79.22
(C(CH3)3), 108.46, 118.64, 119.06, 124.04, 126.75, 129.57, 136.14, 153.25,
159.11, 160.72; IR (CHCl3):   3449 (m), 3017 (m), 2982 (m), 1711 (s), 1567
(m), 1538 (m), 1511 (w), 1470 (m), 1453 (m), 1423 (m), 1402 (m), 1369 (m),
1298 (w), 1252 (s), 1161 (s), 1117 (s), 1097 (s), 1062 (m), 861 (m), 840 cm1
(m); HR-MS (ESI): calcd for C24H38N4O6Si: 506.2561; found: 507.2630
[MH] .
Compound 10c : Obtained similarly, using PPh3 (10.5 g, 40 mmol, 1 equiv),
imidazole (2.7 g, 40 mmol, 1 equiv), I2 (10.15 g, 40 mmol, 1 equiv), com-
pound 9c (9.05 g, 40 mmol, 1 equiv), compound 6 (23.5 g, 72 mmol,
1.8 equiv) and K2CO3 (10.0 g, 72 mmol, 1.8 equiv) and isolated as lightly
red foam (5.5 g, 10.3 mmol, 26%).Rf (hexane/acetone 1:1) 0.55; 1H NMR
(300 MHz, DMSO, 25 C, DMSO):  0.02 (s, 9H; SiMe3), 0.98 (t,
3J(H,H) 8.2 Hz, 2H; CH2SiMe3), 1.17 (m, 2H; CH2), 1.26 (t, 3J(H,H)
7.1 Hz, 3H; OCH2CH3), 1.42 (s, 9; tBu), 1.59 ± 1.70 (m, 4H; 2CH2), 4.15 ±
4.32 (m, 8H; 2COOCH22NCH2), 6.59 (s, 1H; arom. H), 7.03 (s, 1H;
arom. H), 7.11 (s, 1H; arom. H), 7.46 (s, 1H; arom. H), 9.10 (s, 1H; NH);
13C NMR (75 MHz, DMSO, 25 C, DMSO): 0.57 (SiMe3), 14.88
(OCH2CH3), 17.71 (CH2SiMe3), 23.69 (NCH2CH2CH2CH2CH2N), 28.94
(C(CH3)3), 31.13 (NCH2CH2CH2CH2CH2N), 31.44
(NCH2CH2CH2CH2CH2N), 48.23 (NCH2), 48.54 (NCH2), 61.31
(COOCH2), 62.04 (COOCH2), 79.18 (C(CH3)3), 108.24, 118.83, 123.76,
126.92, 129.35, 135.92, 153.26, 159.18, 160.76; IR (CHCl3):   3451 (m),
3020 (m), 2982 (m), 2957 (m), 1710 (s), 1586 (m), 1539 (m), 1508 (w), 1471
(m), 1456 (m), 1422 (m), 1403 (m), 1369 (m), 1252 (s), 1236 (s), 1161 (s),
1119 (m), 1088 (m), 1062 (m), 862 (m), 840 cm1 (m); HR-MS (ESI): calcd
for C26H42N4O6Si: 534.2874; found: 535.294 [MH] .
Compound 10d : In a 1 L bomb compound 14 (9.36 g, 19.6 mmol, 1 equiv)
was dissolved in EtOAc (100 mL) and the solution was purged with Ar.
Then Pd/C (2.26 g, 10%) and Boc2O (4.5 g, 20.6 mmol, 1.05 equiv) were
added and the bomb was pressurized with H2 (35 bar). After stirring at RT
for 5 h all starting material had reacted (detection by NMR of a sample of
the reaction mixture since the starting material and the product are very
hard to separate by TLC). Then the reaction mixture was filtered through
Celite and the solvent was evaporated. Purification of the crude product by
flash column chromatography (hexane/acetone 2:10.1% Et3N) afforded
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compound 10d (8.6 g, 15.7 mmol, 80%) as a colorless foam. Rf (hexane/
acetone 3:2) 0.50; 1H NMR (300 MHz, DMSO, 25 C, DMSO):  0.01
(s, 9H; SiMe3), 0.98 (t, 3J(H,H) 7.7 Hz, 2H; CH2SiMe3), 1.20 (m, 4H;
2CH2), 1.26 (t, 3J(H,H) 7.1 Hz, 3H; OCH2CH3), 1.41 (s, 9H; tBu), 1.44 ±
1.65 (m, 4H; 2NCH2CH2), 4.14 ± 4.31 (m, 8H; 2COOCH22NCH2), 6.59
(s, 1H; arom. H), 7.04 (s, 1H; arom. H), 7.10 (s, 1H; arom. H), 7.47 (s, 1H;
arom. H), 9.11 (s, 1H; NH); 13C NMR (75 MHz, DMSO, 25 C, DMSO):
1.32 (SiMe3), 14.16 (OCH2CH3), 16.97 (CH2SiMe3), 25.56 (2 middle
CH2), 28.19 (C(CH3)3), 30.72 (NCH2CH2), 31.10 (NCH2CH2), 47.60
(NCH2), 47.91 (NCH2), 60.55 (COOCH2), 61.27 (COOCH2), 78.42
(C(CH3)3), 107.47, 118.10, 122.99, 126.18, 128.63, 135.21, 152.51, 158.46,
160.01; IR (CHCl3):   3450 (m), 3007 (m), 2983 (m), 2957 (m), 2863 (w),
1710 (s), 1585 (m), 1537 (m), 1511 (w), 1470 (m), 1455 (m), 1422 (m), 1404
(m), 1252 (s), 1160 (s), 1119 (m), 1102 (m), 1084 (m), 1061 (m), 997 (w), 937
(w), 861 cm1 (m); HR-MS (ESI): calcd for C27H44N4O6Si: 548.3030; found:
549.3106 [MH] .
Compounds 11a ± d : Detailed procedure for the preparation of compound
11b : Compound 10b (4.74 g, 9.1 mmol, 1 equiv) was dissolved in THF and
the solution was cooled in an ice bath. Then TBAF (27.3 mL, 1 solution in
THF, 27.3 mmol, 3 equiv) was added and the reaction mixture was stirred
for 14 h. Then the solvent was evaporated and CH2Cl2 was added. This
organic phase was extracted with aqueous citric acid (0.5). The aqueous
phase was extracted twice with CH2Cl2. Then the organic phases were
combined and extracted with brine, dried with MgSO4 and the solvent was
evaporated, affording the tetrabutylammonium salt of the deprotected acid
(5.4 g, 8.16 mmol, 90%) as a beige foam. An aliquot of this salt (1.0 g,
1.5 mmol, 1 equiv) was dissolved in DMF and HOBt (306 mg, 2.3 mmol,
1.5 equiv) and DCC (1.4 mL, 1 in CH2Cl2, 1.4 mmol, 0.95 equiv) were
added. After stirring at RT for 4 h the reaction mixture was filtered and
MeNH2 (0.8 mL, 2 in THF, 1.6 mmol, 1.05 equiv) and DIEA (261 mL,
1.5 mmol, 1 equiv) were added. After stirring at RT for 20 min the solvent
was evaporated. EtOAc and an aqueous solution of NaHCO3 were added.
After separation of the layers, the aqueous phase was extracted twice with
EtOAc. The combined organic phases were then extracted with brine, dried
with MgSO4 and the solvent was evaporated. Flash column chromatog-
raphy (hexane/acetone 2:30.1% Et3N) afforded compound 11b (473 mg,
0.92 mmol, 61%) as colorless foam. Rf (hexane/acetone 2:3) 0.36;
1H NMR (300 MHz, DMSO, 25 C, DMSO):  1.26 (t, 3J(H,H) 7.1 Hz,
3H; OCH2CH3), 1.41 (s, 9H; tBu), 1.57 (m, 4H; 2NCH2CH2), 2.62 (d,
3J(H,H) 4.4 Hz, 3H; CONHCH3), 4.21 ± 4.32 (m, 6H;
COOCH22NCH2), 6.54 (s, 1H; arom. H), 6.86 (s, 1H; arom. H), 7.03 (s,
1H; arom. H), 7.48 (s, 1H; arom. H), 7.86 (d, 3J(H,H) 4.9 Hz, 1H;
CONHMe), 9.04 (s, 1H; NH (Boc)); 13C NMR (75 MHz, DMSO, 25 C,
DMSO):  14.88 (OCH2CH3), 25.28 (COONHCH3), 26.36 (NCH2CH2),
28.99 (C(CH3)3), 29.17 (NCH2CH2), 47.78 (NCH2), 48.04 (NCH2), 61.36
(COOCH2), 78.94 (C(CH3)3), 103.99, 115.86, 122.98, 127.05, 129.39, 135.96,
153.36, 159.17, 162.11; HR-MS (MALDI): calcd for C21H31N5O5: 433.2325;
found: 456.2210 [MNa] .
Compound 11a : Obtained similarly, using compound 10a (5.0 g, 9.9 mmol,
1 equiv) and TBAF (29.6 mL, 1 in THF, 29.6 mmol, 3 equiv), affording
the tetrabutylammonium salt of the deprotected acid (5.0 g, 7.7 mmol,
78%). A part of it (4.92 g, 7.59 mmol, 1 equiv) was coupled with DCC
(7.21 mL, 1 in CH2Cl2), HOBt (1.54 g, 11.39 mmol, 1.5 equiv), MeNH2
(4.55 mL, 2 in THF, 9.11 mmol, 1.2 equiv) and DIEA (2.64 mL,
15.18 mmol, 2 equiv), affording compound 11a (2.30 g, 5.5 mmol, 72%)
as yellowish foam. Rf (hexane/acetone 2:3) 0.20; 1H NMR (300 MHz,
DMSO, 25 C, DMSO):  1.25 (t, 3J(H,H) 7.1 Hz, 3H; OCH2CH3), 1.41
(s, 9H; tBu), 2.09 (m, 2H; NCH2CH2CH2), 2.63 (d, 3J(H,H) 3.8 Hz, 3H;
CONHCH3), 4.21 ± 4.32 (m, 6H; COOCH22NCH2), 6.57 (s, 1H; arom.
H), 6.86 (s, 1H; arom. H), 7.06 (s, 1H; arom. H), 7.49 (s, 1H; arom. H), 7.86
(d, 3J(H,H) 4.4 Hz, 1H; CONHMe), 9.08 (s, 1H; NH (Boc)); 13C NMR
(75 MHz, DMSO, 25 C, DMSO):  14.89 (OCH2CH3), 26.36
(COONHCH3), 28.99 (C(CH3)3), 33.65 (NCH2CH2), 46.00 (NCH2), 46.34
(NCH2), 61.35 (COOCH2), 78.97 (C(CH3)3), 104.06, 115.60, 123.15, 123.25,
126.70, 129.55, 136.14, 153.36, 159.10, 162.05; IR (CHCl3):   3449 (m),
2936 (m), 1710 (s), 1656 (s), 1592 (m), 1547 (w), 1462 (m), 1384 (m), 1368
(m), 1310 (w), 1156 (s), 1114 (s), 996 cm1 (w); HR-MS (ESI): calcd for
C20H29N5O5: 419.2169; found: 420.2232 [MH] .
Compound 11c : Obtained similarly, using compound 10c (5.2 g, 9.7 mmol,
1 equiv) and TBAF (29.2 mL, 1 in THF, 29.2 mmol, 3 equiv), affording
the tetrabutylammonium salt of the deprotected acid (5.8 g, 8.6 mmol,
88%). A part of it (5.49 g, 8.12 mmol, 1 equiv) was coupled with DCC
(7.71 mL, 1 in CH2Cl2), HOBt (1.65 g, 12.18 mmol, 1.5 equiv), MeNH2
(4.87 mL, 2 in THF, 9.74 mmol, 1.2 equiv) and DIEA (2.83 mL,
16.24 mmol, 2 equiv), affording compound 11c (3.30 g, 7.37 mmol, 91%)
as yellowish foam. Rf (hexane/acetone 2:3) 0.40; 1H NMR (300 MHz,
DMSO, 25 C, DMSO):  1.14 (m, 2H; NCH2CH2CH2), 1.26 (t,
3J(H,H) 7.1 Hz, 3H; OCH2CH3), 1.42 (s, 9H; tBu), 1.56 ± 1.69 (m, 4H;
2NCH2CH2), 2.63 (d, 3J(H,H) 4.4 Hz, 3H; CONHCH3), 4.16 ± 4.31 (m,
6H; COOCH22NCH2), 6.54 (s, 1H; arom. H), 6.86 (s, 1H; arom. H), 7.04
(s, 1H; arom. H), 7.47 (s, 1H; arom. H), 7.85 (d, 3J(H,H) 4.4 Hz, 1H;
CONHMe), 9.03 (s, 1H; NH (Boc)); 13C NMR (75 MHz, DMSO, 25 C,
DMSO):  14.91 (OCH2CH3), 23.78 (NCH2CH2CH2), 26.36
(COONHCH3), 29.00 (C(CH3)3), 31.18 (NCH2CH2), 31.69 (NCH2CH2),
48.17 (NCH2), 48.28 (NCH2), 61.33 (COOCH2), 78.90 (C(CH3)3), 103.92,
115.82, 122.93, 126.97, 129.35, 135.91, 153.36, 159.19, 162.14; IR (CHCl3):
  3451 (w), 3007 (m), 2936 (m), 1713 (s), 1656 (m), 1591 (w), 1534 (s),
1472 (m), 1422 (m), 1394 (m), 1369 (m), 1242 (s), 1161 (s), 1115 (m), 1094
(m), 1069 (m), 997 cm1 (w); HR-MS (ESI): calcd for C22H33N5O5:
447.2482; found: 448.2551 [MH] .
Compound 11d : Obtained similarly, using compound 10d (8.6 g,
15.7 mmol, 1 equiv) and TBAF (47.1 mL, 1 in THF, 47.1 mmol, 3 equiv),
affording the tetrabutylammonium salt of the deprotected acid (9.25 g,
13.4 mmol, 85%). A part of it (2.00 g, 2.9 mmol, 1 equiv) was coupled with
DCC (2.75 mL, 1 in CH2Cl2, 2.75 mmol, 0.95 equiv), HOBt (588 mg,
4.35 mmol, 1.5 equiv), MeNH2 (1.74 mL, 2 in THF, 3.48 mmol, 1.2 equiv)
and DIEA (1 mL, 5.80 mmol, 2 equiv), affording compound 11d (1.17 g,
2.53 mmol, 87%) as yellowish foam. Rf (hexane/acetone 2:3) 0.50;
1H NMR (300 MHz, DMSO, 25 C, DMSO):  1.17 (m, 4H;
2NCH2CH2CH2), 1.26 (t, 3J(H,H) 7.1 Hz, 3H; OCH2CH3), 1.40 (s, 9H;
tBu), 1.43 ± 1.66 (m, 4H; 2NCH2CH2), 2.61 (d, 3J(H,H) 4.4 Hz, 3H;
CONHCH3), 4.13 ± 4.30 (m, 6H; COOCH22NCH2), 6.51 (s, 1H; arom.
H), 6.83 (s, 1H; arom. H), 7.02 (s, 1H; arom. H), 7.46 (s, 1H; arom. H), 7.83
(d, 3J(H,H) 4.9 Hz, 1H; CONHMe), 9.02 (s, 1H; NH (Boc)); 13C NMR
(75 MHz, DMSO, 25 C, DMSO):  14.16 (OCH2CH3), 24.51
(COONHCH3), 25.58 (2NCH2CH2CH2), 28.23 (C(CH3)3), 30.27
(NCH2CH2), 31.32 (NCH2CH2), 47.49 (NCH2), 47.61 (NCH2), 60.57
(COOCH2), 78.15 (C(CH3)3), 103.13, 114.99, 122.12, 122.30, 126.18,
128.62, 135.20, 152.04, 152.61, 158.45, 161.39; IR (CHCl3):   3452 (w),
3006 (m), 2938 (m), 1714 (s), 1654 (m), 1591 (m), 1534 (m), 1472 (m), 1421
(m), 1255 (m), 1160 (m), 1115 (w), 1069 cm1 (w); HR-MS (ESI): calcd for
C23H35N5O5: 461.2638; found: 462.2714 [MH] .
Compounds 12a ± d : Detailed procedure for the preparation of compound
12b : Compound 11b (764 mg, 1.76 mmol, 1 equiv) was dissolved in a
solution of NaOH in MeOH/H2O 1:1 (17.6 mL, 0.1, 1.76 mmol, 1 equiv).
After shaking at 37 C for 2 h the reaction mixture was lyophilized,
affording compound 12b as a colorless foam (712 mg, 1.67 mmol, 95%).
The Na salt of the product is remarkably stable (no decomposition
detectable by NMR or MS(ESI) after storage for seven months at 20 C).
However, it was always freshly prepared before the solid phase synthesis.
Upon acidification the product decarboxylates spontaneously. 1H NMR
(300 MHz, DMSO, 25 C, DMSO):  1.41 (s, 9H; tBu), 1.56 (m, 4H;
2NCH2CH2), 2.63 (d, 3J(H,H) 4.4 Hz, 3H; CONHCH3), 4.21 (br s, 2H;
NCH2), 4.43 (br s, 2H; NCH2), 6.57 (s, 1H; arom. H), 6.73 (s, 1H; arom. H),
6.85 (s, 1H; arom. H), 7.07 (s, 1H; arom. H), 7.90 (d, 3J(H,H) 4.4 Hz, 1H;
CONHMe), 9.05 (s, 1H; NH (Boc)); 13C NMR (75 MHz, DMSO, 25 C,
DMSO):  26.36 (COONHCH3), 29.00 (C(CH3)3), 34.15 (NCH2CH2),
47.08 (NCH2), 47.97 (NCH2), 78.91 (C(CH3)3), 104.08, 115.91, 122.57, 122.98,
126.27, 145.69, 153.39, 162.14, 162.78; HR-MS (ESI): calcd for C19H27N5O5:
405.2012; found: 404.1942 [MH] .
Compound 12a : Obtained similarly, using compound 11a (630 mg,
1.5 mmol, 1 equiv) and a solution of NaOH in MeOH/H2O 1:1 (15 mL,
0.1, 1.5 mmol, 1 equiv) and isolated as colorless foam (615 mg, 1.49 mmol,
99%). 1H NMR (300 MHz, DMSO, 25 C, DMSO):  1.41 (s, 9H; tBu),
2.05 (m, 2H; NCH2CH2), 2.63 (d, 3J(H,H) 3.3 Hz, 3H; CONHCH3), 4.17
(t, 3J(H,H) 7.1 Hz, 2H; NCH2), 4.42 (t, 3J(H,H) 7.1 Hz, 2H; NCH2),
6.58 (s, 1H; arom. H), 6.76 (s, 1H; arom. H), 6.82 (s, 1H; arom. H), 7.06 (s,
1H; arom. H), 7.92 (d, 3J(H,H) 3.8 Hz, 1H; CONHMe), 9.07 (s, 1H; NH
(Boc)); 13C NMR (75 MHz, DMSO, 25 C, DMSO):  26.40
(COONHCH3), 29.01 (C(CH3)3), 34.33 (NCH2CH2), 45.49 (NCH2), 46.35
(NCH2), 78.96 (C(CH3)3), 104.10, 115.51, 122.36, 123.19, 126.51, 145.78,
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153.39, 162.12, 162.78; HR-MS (ESI): calcd for C18H25N5O5: 391.1856;
found: 414.1735 [MNa] , 392.1916 [MH] .
Compound 12c : Obtained similarly, using compound 11c (671 mg,
1.5 mmol, 1 equiv) and a solution of NaOH in MeOH/H2O 1:1 (15 mL,
0.1, 1.5 mmol, 1 equiv) and isolated as colorless foam (666 mg, 1.50 mmol,
99%). 1H NMR (300 MHz, DMSO, 25 C, DMSO):  1.11 (m, 2H; CH2),
1.42 (s, 9H; tBu), 1.62 (m, 4H; 2NCH2CH2), 2.63 (s, 3H; CONHCH3), 4.16
(t, 3J(H,H) 7.1 Hz, 2H; NCH2), 4.40 (t, 3J(H,H) 7.1 Hz, 2H; NCH2),
6.55 (s, 1H; arom. H), 6.73 (s, 1H; arom. H), 6.85 (s, 1H; arom. H), 7.05 (s,
1H; arom. H), 7.89 (br s, 1H; NH); 13C NMR (75 MHz, DMSO, 25 C,
DMSO):  23.99 (CH2), 26.38 (COONHCH3), 29.02 (C(CH3)3), 31.68
(NCH2CH2), 31.92 (NCH2CH2), 47.51 (NCH2), 48.26 (NCH2), 78.88
(C(CH3)3), 104.05, 115.87, 122.62, 123.03, 126.24, 145.59, 153.43, 162.20,
162.90; HR-MS (ESI): calcd for C20H29N5O5: 419.2169; found: 442.2051
[MNa] , 420.2231 [MH] .
Compound 12d : Obtained similarly, using compound 11d (27 mg,
58.5 mmol, 1 equiv) and a solution of NaOH in MeOH/H2O 1:1 (585 mL,
0.1, 58.5 mmol, 1 equiv) (additional H2O (1 mL) and MeOH (2 mL) had
to be added to completely dissolve the starting material) and isolated as
yellowish foam (22 mg, 45.7 mmol, 79%). 1H NMR (300 MHz, DMSO,
25 C, DMSO):  1.15 (m, 4H; 2NCH2CH2CH2), 1.42 (s, 9H; tBu), 1.54 ±
1.62 (m, 4H; 2NCH2CH2), 2.63 (d, 3J(H,H) 4.4 Hz, 3H; CONHCH3),
4.15 (t, 3J(H,H) 6.6 Hz, 2H; NCH2), 4.40 (t, 3J(H,H) 6.6 Hz, 2H;
NCH2), 6.54 (s, 1H; arom. H), 6.72 (s, 1H; arom. H), 6.84 (s, 1H; arom. H),
7.04 (s, 1H; arom. H), 7.89 (d, 3J(H,H) 3.8 Hz, 1H; COONHMe), 9.04 (s,
1H; NH (Boc)); 13C NMR (75 MHz, DMSO, 25 C, DMSO):  24.60
(COONHCH3), 25.63 (NCH2CH2CH2), 25.78 (NCH2CH2CH2), 28.26
(C(CH3)3), 31.25 (NCH2CH2), 31.44 (NCH2CH2), 46.76 (NCH2), 47.56
(NCH2), 78.15 (C(CH3)3), 103.24, 115.01, 121.71, 122.13, 122.38, 125.46,
145.02, 152.63, 161.46, 162.07; HR-MS (ESI): calcd for C21H31N5O5:
433.2325; found: 432.2263 [MH] .
Compound 14 : PPh3 (8.73 g, 33.3 mmol, 1 equiv) and imidazole (2.27 g,
33.3 mmol, 1 equiv) were dissolved in CH2Cl2 and I2 (8.45 g, 33.3 mmol,
1 equiv) was added. After stirring at RT for 10 min compound 9d (8.0 g,
33.3 mmol, 1 equiv) was diluted with CH2Cl2 and added. After stirring at
RT for 10 min the reaction mixture was shaken with an aqueous solution of
Na2S2O3 and the phases were separated. The aqueous layer was extracted
three times with CH2Cl2. The combined organic layers were extracted with
brine, dried with MgSO4 and the solvent was evaporated. The resulting
orange residue (20 g) was dissolved in MeCN and compound 5 (10.0 g,
40 mmol, 1.2 equiv) and K2CO3 (11.5 g, 83.2 mmol, 2.5 equiv) were added.
This mixture was heated to 80 C with vigorous stirring for 3 h. After
filtration the solvent was evaporated and CH2Cl2 and aqueous NaHCO3
were added. After separation of the layers the aqueous phase was extracted
twice with CH2Cl2. The combined organic phases were extracted with
brine, dried with MgSO4 and the solvent was evaporated. The residue was
subjected to flash column chromatography (hexane/acetone 2:11%
Et3N), affording compound 14 as a yellow liquid (10.55 g, 22 mmol,
66%). Rf (hexane/acetone 3:2) 0.50; 1H (300 MHz, CDCl3, 25 C, TMS):
 0.05 (s, 9H; SiMe3), 0.98 (t, 3J(H,H) 8.2 Hz, 2H; CH2SiMe3), 1.33 (m,
4H; 2CH2), 1.40 (t, 3J(H,H) 7.1 Hz, 3H; OCH2CH3), 1.77 (m, 4H; 2CH2),
4.29 ± 4.41 (m, 8H; 2COOCH22NCH2), 7.04 (s, 1H; arom. H), 7.12 (s, 1H;
arom. H), 7.37 (d, 3J(H,H) 2.2 Hz, 1H; arom. H), 7.59 (d, 3J(H,H)
2.2 Hz, 1H; arom. H); 13C NMR (75 MHz, CDCl3, 25 C, CDCl3): 
1.42 (SiMe3), 14.31 (OCH2CH3), 17.39 (CH2SiMe3), 25.97 (2 middle
CH2), 30.93 (NCH2CH2), 30.98 (NCH2CH2), 48.26 (NCH2), 50.22 (NCH2),
61.35 (COOCH2), 63.26 (COOCH2), 112.74, 122.40, 125.00, 126.45, 129.34,
135.13, 157.13, 158.89, 159.91; IR (CHCl3):   3143 (m), 2985 (s), 2958 (s),
2863 (s), 1711 (s), 1540 (s), 1511 (s), 1473 (s), 1422 (s), 1385 (s), 1371 (s),
1318 (s), 1252 (s), 1151 (s), 1107 (s), 1082 (s), 925 cm1 (m); HR-MS (ESI):
calcd for C22H34N4O6Si: 478.2248; found: 479.2324 [MH] .
Compound 15 : Obtained analogously to compound 11d, using compound
10d (8.6 g, 15.7 mmol, 1 equiv) and TBAF (47.1 mL, 1 in THF, 47.1 mmol,
3 equiv), affording the tetrabutylammonium salt of the deprotected acid
(9.25 g, 13.4 mmol, 85%). A part of it (2.00 g, 2.9 mmol, 1 equiv) was
coupled with DCC (2.75 mL, 1 in CH2Cl2, 2.75 mmol, 0.95 equiv), HOBt
(588 mg, 4.35 mmol, 1.5 equiv), NH3 (7.0 mL, 0.5 in dioxane, 3.48 mmol,
1.2 equiv) and DIEA (1 mL, 5.80 mmol, 2 equiv), affording compound 15
(1.2 g, 2.68 mmol, 92%) as colorless foam. Rf (hexane/acetone 2:3) 0.38;
1H NMR (300 MHz, DMSO, 25 C, DMSO):  1.16 (m, 4H;
2NCH2CH2CH2), 1.25 (t, 3J(H,H) 7.1 Hz, 3H; OCH2CH3), 1.40 (s, 9H;
tBu), 1.43 ± 1.66 (m, 4H; 2NCH2CH2), 4.14 ± 4.30 (m, 6H;
COOCH22NCH2), 6.58 (s, 1H; arom. H), 6.70 (br s, 1H; CONH2), 6.84
(s, 1H; arom. H), 7.02 (s, 1H; arom. H), 7.38 (br s, 1H; CONH2), 7.46 (s, 1H;
arom. H), 8.99 (s, 1H; NH (Boc)); 13C NMR (75 MHz, DMSO, 25 C,
DMSO):  14.17 (OCH2CH3), 25.54 (2 NCH2CH2CH2), 28.24 (C(CH3)3),
30.71 (NCH2CH2), 31.26 (NCH2CH2), 47.52 (NCH2), 47.61 (NCH2), 60.58
(COOCH2), 78.13 (C(CH3)3), 104.40, 115.67, 121.90, 122.00, 128.64, 135.20,
152.67, 158.45, 162.71; IR (CHCl3):   3534 (w), 3449 (w), 3417 (w), 2984
(m), 2938 (m), 2862 (m), 1713 (s), 1665 (s), 1599 (w), 1575 (m), 1536 (w),
1510 (w), 1467 (w), 1423 (w), 1323 (w), 1255 (m), 1160 (s), 1121 (w), 1070
(w), 998 cm1 (w); HR-MS (ESI): calcd for C22H33N5O5: 447.2482; found:
448.2558 [MH] .
Compound 16 : Obtained analogously to compound 12d, using compound
15 (31 mg, 69.3 mmol, 1 equiv) and a solution of NaOH in MeOH/H2O 1:1
(693 mL, 0.1, 69.3 mmol, 1 equiv) (additional MeOH (1.5 mL) had to be
added to completely dissolve the starting material) and isolated as
yellowish foam (23 mg, 49.6 mmol, 72%). 1H NMR (300 MHz, DMSO,
25 C, DMSO):  1.15 (m, 4H; 2NCH2CH2CH2), 1.41 (s, 9H; tBu), 1.54 ±
1.62 (m, 4H; 2NCH2CH2), 4.16 (t, 3J(H,H) 6.6 Hz, 2H; NCH2), 4.40 (t,
3J(H,H) 7.1 Hz, 2H; NCH2), 6.60 (s, 1H; arom. H), 6.72 (s, 1H; arom. H),
6.84 (s, 1H; arom. H), 7.05 (s, 1H; arom. H); 13C NMR (75 MHz, DMSO,
25 C, DMSO):  25.75 (NCH2CH2CH2), 28.28 (C(CH3)3), 31.20
(NCH2CH2), 31.39 (NCH2CH2), 46.77 (NCH2), 47.57 (NCH2), 78.00
(C(CH3)3), 104.53, 115.77, 121.87, 122.32, 125.49, 144.94, 152.83, 162.82;
HR-MS (ESI): calcd for C20H29N5O5: 419.2169; found: 442.2057 [MNa] .
Compound 17: PPh3 (5.25 g, 20 mmol, 1 equiv) and imidazole (1.36 g,
20 mmol, 1 equiv) were dissolved in CH2Cl2 and I2 (5.08 g, 20 mmol,
1 equiv) was added. After stirring at RT for 10 min compound 9d (4.81 g,
20 mmol, 1 equiv) was dissolved in CH2Cl2 and added. After stirring at RT
for 10 min the reaction mixture was shaken with an aqueous solution of
Na2S2O3 and the layers were separated. The aqueous layer was extracted
three times with CH2Cl2. Then the combined organic layers were extracted
with brine, dried with MgSO4 and the solvent was evaporated. The orange
residue (14.5 g) was purified by flash column chromatography (hexanes/
acetone 2:1) to afford compound 17 (5.25 g, 15 mmol, 75%) as yellow oil.
Rf (hexane/acetone 2:1) 0.45; 1H (300 MHz, CDCl3, 25 C, TMS): 
1.34 ± 1.46 (m, 7H; 2CH2OCH2CH3), 1.77 ± 1.84 (m, 4H;
ICH2CH2NCH2CH2), 3.17 (t, 3J(H,H) 7.1 Hz, 2H; CH2I), 4.37 ± 4.44
(m, 4H; 2COOCH2NCH2), 7.11 (s, 1H; arom. H), 7.15 (s, 1H; arom. H);
13C NMR (75 MHz, CDCl3, 25 C, CDCl3):  6.61 (CH2I), 14.03
(OCH2CH3), 25.10 (NCH2CH2CH2), 29.58 (ICH2CH2CH2), 30.68
(NCH2CH2), 32.84 (ICH2CH2), 47.96 (NCH2), 60.94 (COOCH2), 124.75
(C5 of imidazole), 128.93 (C4 of imidazole, 135.51 (C2 of imidazole), 158.48
(CO); IR (CHCl3):   2986 (s), 2939 (s), 2861 (m), 1710 (s), 1511 (w), 1473
(s), 1422 (s), 1386 (s), 1304 (m), 1257 (s), 1141 (s), 1108 (s), 1071 (m),
1011 cm1 (w); HR-MS (ESI): calcd for C12H29N2O2I: 350.0491; found:
351.0568 [MH] .
Compound 18 : Compound 17 (3.47 g, 9.9 mmol, 1.1 equiv) was dissolved in
MeCN (50 mL). Then 3-nitropyrrole[13] (1.01 g, 9.0 mmol, 1.0 equiv) and
K2CO3 (2.5 g, 18.0 mmol, 2.0 equiv) were added and the reaction mixture
was heated to 80 C for 12 h. After filtration the solvent was evaporated.
CH2Cl2 and an aqueous solution of NaHCO3 were added. After separation
of the layers the aqueous layer was extracted twice with CH2Cl2. The
combined organic phases were extracted with brine, dried with MgSO4 and
the solvent was evaporated. The crude product was purified by flash
column chromatography (hexane/acetone 2:10.1% Et3N), affording
compound 18 (2.03 g, 6.07 mmol, 67%) as a yellowish oil. Rf (ethyl
acetate) 0.40; 1H (300 MHz, CDCl3, 25 C, TMS):  1.33 ± 1.46 (m, 7H;
2CH2OCH2CH3), 1.79 ± 1.82 (m, 4H; 2NCH2CH2), 3.88 (t, 3J(H,H)
7.1 Hz, 2H; N(Py)CH2), 4.40 (m, 4H; 2COOCH2N(Im)CH2), 6.54 (t,
3J(H,H) 2.7 Hz, 1H; H4 of Py), 6.70 (dd, 3J(H,H) 1.8, 2.7 Hz, 1H; H5 of
Py), 7.06 (d, 3J(H,H) 0.9 Hz, 1H; H5 of Im), 7.15 (d, 3J(H,H) 1.2 Hz,
1H; H4 of Im), 7.50 (t, 3J(H,H) 2.1 Hz, 1H; H2 of Py); 13C NMR
(75 MHz, CDCl3, 25 C, CDCl3):  14.32 (OCH2CH3), 25.95
(NCH2CH2CH2), 30.64 (NCH2CH2), 30.95 (NCH2CH2), 48.20 (N(Im)CH2),
50.63 (N(Py)CH2), 61.38 (COOCH2), 105.52 (C5 of Py), 121.14 (C2 or C4 of
Py), 121.35 (C4 or C2 of Py), 125.00 (C5 of Im), 129.38 (C4 of Im), 135.87
(C3 of Py or C2 of Im), 136.58 (C2 of Im or C3 of Py), 158.90 (CO); IR
(CDCl3):   2943 (m), 2863 (w), 1710 (s), 1532 (m), 1514 (m), 1489 (s), 1473
(m), 1422 (s), 1385 (m), 1365 (m), 1294 (s), 1257 (m), 1155 (m), 1129 (m),
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1072 cm1 (m); HR-MS (ESI): calcd for C16H22N4O4: 334.1641; found:
335.1716 [MH] .
Compound 19 : Compound 18 (0.9 g, 2.7 mmol, 1 equiv) was dissolved in
EtOAc and Boc2O (617 mg, 2.83 mmol, 1.05 equiv) was added. After
purging the solution with Ar, Pd/C (311 mg, 10%) was added. This mixture
was stirred under a H2 atmosphere (35 bar) at RT for 3.5 h. Then it was
filtered and the solvent was evaporated. Purification by flash column
chromatography (hexane/acetone 2:10.1% Et3N) afforded compound 19
as a colorless oil (0.96 g, 2.37 mmol, 88%). Rf (hexane/acetone 1:1) 0.56;
1H (300 MHz, CDCl3, 25 C, TMS):  1.30 (m, 4H; 2CH2), 1.43 (t,
3J(H,H) 7.1 Hz, 3H; OCH2CH3), 1.49 (s, 9H; tBu), 1.70 ± 1.80 (m, 4H;
2NCH2CH2), 3.76 (t, 3J(H,H) 7.1 Hz, 2H; N(Py)CH2), 4.34 ± 4.44 (m, 4H;
2COOCH2N(Im)CH2), 5.85 (t, 3J(H,H) 2.2 Hz, 1H; C4 of Py), 6.24
(br s, 1H; NH), 6.43 (t, 3J(H,H) 2.7 Hz, 1H; C5 of Py), 6.87 (br s, 1H; C2
of Py), 7.04 (s, 1H; C5 of Im), 7.14 (s, 1H; C4 of Im); 13C NMR (75 MHz,
CDCl3, 25 C, CDCl3):  14.37 (OCH2CH3), 26.14 (NCH2CH2CH2), 26.26
(NCH2CH2CH2), 28.46 (C(CH3)3), 31.10 (2 NCH2CH2), 48.38 (N(Im)CH2),
49.78 (N(Py)CH2), 61.36 (COOCH2), 79.56 (C(CH3)3), 99.86 (C4 of Py),
109.91 (C2 or C5 of Py), 118.52 (C5 or C2 of Py), 122.58 (C3 of Py), 125.08
(C5 of Im), 129.35 (C4 of Im), 135.93 (C2 of Im), 157.10 (CO (Boc)), 158.93
(COOEt); IR (CHCl3):   2956 (m), 2863 (w), 1712 (s), 1577 (w), 1540 (m),
1491 (m), 1422 (m), 1390 (m), 1369 (m), 1312 (w), 1250 (s), 1165 (s), 1120
(m), 1072 (w), 1059 (w), 1019 cm1 (w); HR-MS (ESI): calcd for
C21H32N4O4: 404.2424; found: 405.2499 [MH] .
Compound 20 : Compound 19 (291 mg, 0.72 mmol, 1 equiv) was dissolved
in a solution of NaOH in MeOH/H2O 1:1 (3.6 mL, 0.2, 0.72 mmol,
1 equiv). After shaking at 37 C for 12 h the reaction mixture was
lyophilized, affording compound 20 as a yellowish foam (280 mg,
0.70 mmol, 98%). This compound was always freshly prepared before
the solid-phase synthesis. 1H NMR (300 MHz, DMSO, 25 C, DMSO): 
1.18 (m, 4H; 2CH2), 1.41 (s, 9H; tBu), 1.59 ± 1.64 (m, 4H; 2NCH2CH2), 3.70
(t, 3J(H,H) 7.1 Hz; 2H, NCH2), 4.42 (t, 3J(H,H) 7.1 Hz; 2H; NCH2),
5.79 (s, 1H; arom. H), 6.46 (s, 1H; arom. H), 6.70 (s, 1H; arom. H), 6.74 (s,
1H; arom. H), 7.06 (s, 1H; arom. H); 13C NMR (75 MHz, DMSO, 25 C,
DMSO):  25.68 (NCH2CH2CH2), 25.79 (NCH2CH2CH2), 28.37
(C(CH3)3), 30.93 (NCH2CH2), 31.16 (NCH2CH2), 46.76 (NCH2), 48.72
(NCH2), 77.22 (C(CH3)3), 99.86, 108.77, 118.01, 121.78, 124.48, 125.47,
144.93, 152.99, 162.09; HR-MS (ESI): calcd for C19H28N4O4: 376.2111;
found: 399.2011 [MNa] .
Construction of plasmid DNA : To obtain the plasmid pAH2, the
oligonucleotide strands printed in bold face in Figure 6 were hybridized
and then ligated (Roche rapid ligation kit) into linearized pUC19[17]
(BamHI/HindIII) using T4 DNA ligase. The resultant construct was used
to transform JM109 cells (Promega). Ampicillin-resistant white colonies
were selected from Luria-Bertani medium-agar plates containing ampicil-
lin (50 mg mL1), IPTG (120 mg mL1) and XGAL (40 mg mL1) and
grown in Luria-Bertani medium. Then the plasmid was isolated using the
Qiagen HiSpeed Plasmid Purification Kit. The sequence was verified by
dideoxy sequencing using the primers PBD1f (5-
CTGCGCAACTGTTGGGAAGGG-3) and PBD1r (5-GGGCAGT-
GAGCGCAACGCAAT-3). The plasmid pDEH9 had been prepared in
a similar way by S. E. Swalley and D. E. Herman.
Preparation of 3-end-labeled restriction fragments : Following a literature
procedure,[20] the plasmids pDEH9 and pAH2 were linearized with EcoRI
and PvuII and then treated with Klenow enzyme, deoxyadenosine 5-[a-
32P]triphosphate and thymidine 5-[a-32P]triphosphate. After separation on
a nondenaturing polyacrylamide gel the desired band was visualized by
autoradiography and isolated. Chemical sequencing reactions were per-
formed according to published methods.[21]
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